Cholera

Clinical Microbiology Reviews

Volumn 8, Issue 1, 1995, Pages 48-86

  Kaper, James B ^a   Morris Jr , J Glenn ^a   Levine, Myron M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CHOLERA TOXIN; CHOLERA VACCINE; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; PHENYLBUTAZONE; TETRACYCLINE; VIRULENCE FACTOR;

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL IMMUNITY; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIOTYPOLOGY; CHOLERA; CLINICAL FEATURE; DISEASE TRANSMISSION; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; REHYDRATION; REVIEW; SEASONAL VARIATION; SEROTYPING; TAXONOMY; VACCINATION; VIBRIO CHOLERAE;

BACTERIA (MICROORGANISMS); VIBRIO CHOLERAE;

EID: 0028855105     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/cmr.8.1.48-86.1995     Document Type: Review

References (493)

1. Abbott, S. L., and J. M. Janda. 1993. Rapid detection of acute cholera in airline passengers by coagglutination assay. J. Infect. Dis. 168:797-799.
2. Albert, M. J., M. Ansaruzzaman, P. K. Bardhan, A. S. G. Panique, S. M. Faruque, M. S. Islam, D. Mahalanabis, R. B. Sack, M. A. Salam, A. K. Siddique, M. D. Yunus, and K. Zaman. 1993. Large epidemic of choleralike disease in Bangladesh caused hy Vibrio cholerae 0139 synonym Bengal. Lancet 342:387-390.
3. Albert, M. J., A. K. Siddique, M. S. Islam, A. S. G. Faruque, M. Ansaruzzaman, S. M. Faruque, and R. B. Sack. 1993. Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh. Lancet 341:704.
4. Alm, R. A., G. Braun, R. Morona, and P. A. Manning. 1986. Detection of an OmpA-like protein in Vibrio cholerae. FEMS Microbiol. Lett. 37:99-104.
5. Alm, R. A., and P. A. Manning. 1990. Biotype-specific probe for Vibrio cholerae serogroup O1 J. Clin. Microbiol. 28:823-824.
6. Alm, R. A., U. H. Stroeher, and P. A. Manning. 1988. Extracellular proteins of Vibrio cholerae: nucleotide sequence of the structural gene (hlyA) for the haemolysin of the haemolytic El Tor strain O17 and characterization of the hlyA mutation in the non-haemolytic classical strain 569B. Mol. Microbiol. 2:481-488.
7. Almeida, R. J., F. W. Hickman-Brenner, E. G. Sowers, N. D. Puhr, J. J. Farmer, III, and I. K. Wachsmuth. 1990. Comparison of a latex agglutination assay and an enzyme-linked immunosorbent assay for detecting cholera toxin. J. Clin. Microbiol. 28:128-130.
8. Apter, F. M., P. Michetti, L. S. Winner, III, J. A. Mack, J. J. Mekalanos, and M. R. Neutra. 1993. Analysis of the roles of antilipopolysaccharide and anti-cholera toxin immunoglobulin A (IgA) antibodies in protection against Vibrio cholerae and cholera toxin by use of monoclonal IgA antibodies in vivo. Infect. Immun. 61:5279-5285.
9. Attridge, S. R., C. Dearlove, L. Beyer, L. van den Bosch, A. Hernies, J. Hackett, R. Morona, J. LaBrooy, and D. Rowley. 1991. Characterization and immunogenicity of EX880, a Salmonella typhi Ty21a-based clone which produces Vibrio cholerae O antigen. Infect. Immun. 59:2279-2284.
10. Attridge, S. R., and D. Rowley. 1983. The role of the flagellum in the adherence of Vibrio cholerae. J. Infect. Dis. 147:864-872.
11. Attridge, S. R., and D. Rowley. 1983. The specificity of Vibrio cholerae adherence and the significance of the slime agglutinin as a second mediator of in vitro attachment. J. Infect. Dis. 147:873-881.
12. Azurin, J. C., K. Kobari, M. Alvero, C. Z. Gomez, J. J. Dizon, E.-I. Nakano, R. Suplido, and L. Ledesma. 1967. A long-term carrier of cholera: cholera Dolores. Bull. W. H. O. 37:745-749.
13. Bagchi, K., P. Echeverria, J. D. Arthur, O. Sethabutr, O. Serichantalergs, and C. W. Hoge. 1993. Epidemic of diarrhea caused by Vibrio cholerae non-Ol that produced heat-stable toxin among Khmers in a camp in Thailand. J. Clin. Microbiol. 31:1315-1317.
14. Baine, W. B., A. Zampieri, M. Mazzotti, G. Angioni, D. Greco, D. Gioia, E. Izzo, E. J. Gangarosa, and F. Pocchiari. 1974. Epidemiology of cholera in Italy in 1973. Lancet ii:1370-1375.
15. Barrett, T. J., and P. A. Blake. 1981. Epidemiological usefulness of changes in hemolytic activity of Vibrio cholerae biotype El Tor during the seventh pandemic. J. Clin. Microbiol. 13:126-129.
16. Bart, K. J., Z. Huq, M. Khan, and W. H. Mosley. 1970. Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. J. Infect. Dis. 121(Suppl.):S17-S24.
17. Bartowsky, E. J., S. R. Attridge, C. J. Thomas, G. Mayrhofer, and P. A. Manning. 1990. Role of the P plasmid in attenuation of Vibrio cholerae O1 Infect. Immun. 58:3129-3134.
18. Baselski, V., R. Briggs, and C. Parker. 1977. Intestinal fluid accumulation induced by oral challenge with Vibrio cholerae or cholera toxin in infant mice. Infect. Immun. 15:704-712.
19. Baudry, B., A. Fasano, J. Ketley, and J. B. Kaper. 1992. Cloning of a gene (zot) encoding a new toxin produced by Vibrio cholerae. Infect. Immun. 60:428-434.
20. Baumann, P., A. L. Furniss, and J. V. Lee. 1984. Genus I. Vibrio, p. 518-538. In N. R. Krieg and J. G. Holt (ed.), Bergey's manual of systematic bacteriology, vol. 1. Williams & Wilkins, Baltimore.
21. Bear, C. E., C. Li, N. Kartner, R. J. Bridges, T. J. Jensen, M. Ramjeesingh, and J. R. Riordan. 1992. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell 68:809-818.
22. Benenson, A. S., A. Saad, W. H. Mosley, and A. Ahmed. 1968. Serological studies in cholera. 3. Serum toxin neutralization-rise in titre in response to infection with Vibrio cholerae, and the level in the "normal" population in East Pakistan. Bull. W. H. O. 38:287-295.
23. Bennett, A. 1971. Cholera and prostaglandins. Nature (London) 231:536.
24. Bennish, M. L. 1994. Cholera: pathophysiology, clinical features, and treatment, p. 229-255. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
25. Berschneider, H. M., M. R. Knowles, R. G. Azizkhan, R. C. Boucher, N. A. Tobey, R. C. Orlando, and D. W. Powell. 1988. Altered intestinal chloride transport in cystic fibrosis. FASEB J. 2:2625-2629.
26. Besser, R., D. Feikin, J. Eberhart-Phillips, L. Mascola, and P. Griffin. 1992. Cholera in the United States: are we prepared to treat it? Program Abstr. 32nd Intersci. Conf. Antimicrob. Agents Chemother, abstr. 943.
27. 2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo. Gastroenterology 96:368-376.
28. Bhattacharya, S. K., M. K. Bbattacharya, G. B. Nair, D. Dutta, A. Deb, T. Ramamurthy, S. Garg, P. K. Saha, P. Dutta, A. Moitra, B. K. Mandai, T. Shimada, Y. Takeda, and B. C. Deb. 1993. Clinical profile of acute diarrhoea cases infected with the new epidemic strain of Vibrio cholerae O139: designation of the disease as cholera. J. Infect. 27:11-15.
29. Billings, J. S., E. McClellan, and J. C. Peters. 1975. The cholera epidemic of 1873 in the United States. Document 95, 43rd Congress, 2nd session, p. 1-1025. U.S. Government Printing Office, Washington, D.C.
30. Black, R. E. 1982. The prophylaxis and therapy of secretory diarrhea. Med. Clin. North Am. 66:611-621.
31. Blake, P. A., D. T. Allegra, J. D. Snyder, T. J. Barrett, L. McFarland, C. T. Caraway, J. C. Feeley, J. P. Craig, J. V. Lee, N. D. Puhr, and R. A. Feldman. 1980. Cholera-a possible endemic focus in the United States. N. Engl. J. Med. 302:305-309.
32. Bornside, G. H. 1981. Jaime Ferran and preventive inoculation against cholera. Bull. Hist. Med. 55:516-532.
33. Brayton, P. R., M. L. Tamplin, A. Huq, and R. R. Colwell. 1987. Enumeration of Vibrio cholerae Ol in Bangladesh waters by fluorescent-antibody direct viable count. Appl. Environ. Microbiol. 53:2862-2865.
34. Brenner, D. J., B. R. Davis, Y. Kudoh, M. Ohashi, R. Sakazaki, T. Shimada, and H. L. Smith, Jr. 1982. Serological comparison of two collections of Vibrio cholerae non-O1. J. Clin. Microbiol. 16:319-323.
35. Bromander, A., J. Holmgren, and N. Lycke. 1991. Cholera toxin stimulates IL-I production and enhances antigen presentation by macrophages in vitro. J. Immunol. 146:2908-2914.
36. Brown, M. H., and P. A. Manning. 1985. Haemolysin genes of Vibrio cholerae'. presence of homologous DNA in non-haemolytic O1 and haemolytic non-O1 strains. FEMS Microbiol. Lett. 30:197-201.
37. Butterton, J. R., J. A. Stoebner, S. M. Payne, and S. B. Calderwood. 1992. Cloning, sequencing, and transcriptional regulation of viuA, the gene encoding the ferric vibriobactin receptor of Vibrio cholerae. J. Bacteriol. 174:3729-3738.
38. Calderwood, S. B., and J. J. Mekalanos. 1987. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J. Bacteriol. 169:4759-4764.
39. Cash, R. A., S. I. Music, J. P. Libonati, M. J. Snyder, R. P. Wenzel, and R. B. Hornick. 1974. Response of man to infection with Vibrio cholerae. I. Clinical, serologic, and bacteriologic responses to a known inoculum. J. Infect. Dis. 129:45-52.
40. Cassel, D., and Z. Selinger. 1977. Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. USA 74:3307-3311.
41. Cassuto, J., J. Fahrenkrug, M. Jodal, R. Tuttle, and O. Lundgren. 1981. The release of vasoactive intestinal polypeptide from the cat small intestine exposed to cholera toxin. Gut 22:958-963.
42. Cassuto, J., M. Jodal, and O. Lundgren. 1982. The effect of nicotinic and muscarinic receptor blockade on cholera toxin induced intestinal secretion in rats and cats. Acta Physiol. Scand. 114:573-577.
43. Cassuto, J., M. Jodal, R. Tuttle, and O. Lundgren. 1981. On the role of intramural nerves in the pathogenesis of cholera toxin-induced intestinal secretion. Scand. J. Gastroenterol. 16:377-384.
44. Cassuto, J., A. Siewert, M. Jodal, and O. Lundgren. 1983. The involvement of intramural nerves in cholera toxin induced intestinal secretion. Acta Physiol. Scand. 117:195-202.
45. Centers for Disease Control. 1993. Imported cholera associated with a newly described toxigenic Vibrio cholerae O139 strain - California, 1993. Morbid. Mortal. Weekly Rep. 42:501-503.
46. Chaicumpa, W., and N. Atthasisishtha. 1977. Study of intestinal immunity against V. cholerae'. role of antibody to V. cholerae haemagglutinin in intestinal immunity. Southeast Asian J. Trop. Med. Public Health 8:13-18.
47. Chaicumpa, W., A. Boonthum, T. Kalumbaheti, and et al. 1984. Cell-bound haemagglutinin (CHA) of V. cholerae O1 as protective antigen. Southeast Asian J. Trop. Med. Public Health 15:407-413.
48. Chambers, J. S. 1938. Cholera's first invasion of the New World, p. 24-44. In The conquest of cholera. MacMillan, New York.
49. Chambers, J. S. 1938. Pestilence of 1832 along the Atlantic seaboard, p. 45-84. In The conquest of cholera. MacMillan, New York.
50. Chang, E. B., and M. C. Rao. 1991. Intracellular mediators of intestinal electrolyte transport, p. 49-72. In M. Field (ed.), Diarrheal diseases. Elsevier, New York.
51. Chattopadhyay, D. J., B. L. Sarkar, M. Q. Ansari, B. K. Chakrabarti, M. K. Roy, A. N. Ghosh, and S. C. Pal. 1993. New phage typing scheme for Vibrio cholerae Ol biotype E1 Tor strains. J. Clin. Microbiol. 31:1579-1585.
52. Chitnis, D. S., K. D. Sharma, and R. S. Kamat. 1982. Role of somatic antigen of Vibrio cholerae in adhesion to inestinal mucosa. J. Med. Microbiol. 5:53-61.
53. Cholera Working Group. 1993. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Lancet 342:387-390.
54. Chongsa-nguan, M., W. Chaicumpa, P. Moolasart, P. Kandhasingha, T. Shimada, H. Kurazono, and Y. Takeda. 1993. Vibrio cholerae O139 Bengal in Bangkok. Lancet 342:430-431.
55. Clemens, J. D., D. A. Sack, J. R. Harris, J. Chakraborty, M. R. Khan, S. Huda, F. Ahmed, J. Goes, M. R. Rao, A.-M. Svennerholm, and J. Holmgren. 1989. ABO blood groups and cholera: new observations on specificity of risk and modification of vaccine efficacy. J. Infect. Dis. 159:770-773.
56. Clemens, J. D., D. A. Sack, J. R. Harris, J. Chakraborty, M. R. Khan, B. F. Stanton, B. A. Kay, M. U. Khan, M. Yunus, W. Atkinson, A.-M. Svennerholm, and J. Holmgren. 1986. Field trial of oral cholera vaccines in Bangladesh. Lancet ii:124-127.
57. Clemens, J. D., D. A. Sack, J. R. Harris, J. Chakraborty, P. K. Neogy, B. Stanton, N. Huda, M. U. Khan, B. A. Kay, M. R. Khan, M. Ansaruzzaman, M. Yunus, M. R. Rao, A.-M. Svennerholm, and J. Holmgren. 1988. Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial. J. Infect. Dis. 158:372-377.
58. Clemens, J. D., D. A. Sack, J. R. Harris, M. R. Khan, J. Chakraborty, S. Chowdhury, M. R. Rao, F. P. L. Van Loon, B. F. Stanton, M. Yunus, M. Ali, M. Ansaruzzaman, A.-M. Svennerholm, and J. Holmgren. 1990. Breast feeding and the risk of severe cholera in rural Bangladesh children. Am. J. Epidemiol. 131:400-411.
59. Clemens, J. D., F. van Loon, D. A. Sack, M. R. Rao, F. Ahmed, J. Chakraborty, B. A. Kay, M. R. Khan, M. Yunus, J. R. Harris, A.-M. Svennerholm, and J. Holmgren. 1991. Biotype as determinant of natural immunising effect of cholera. Lancet 337:883-884.
60. Clements, J. D., and S. EI-Morshidy. 1984. Construction of a potential live oral bivalent vaccine for typhoid fever and cholera-Escherichia coli-related diarrheas. Infect. Immun. 46:564-569.
61. Clements, M. L., M. M. Levine, C. R. Young, R. E. Black, Y. L. Lim, R. M. Robins Browne, and J. P. Craig. 1982. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J. Infect. Dis. 145:465-473.
62. Cohen, J., T. Schwartz, R. Klasmer, D. Pridan, H. Ghalayini, and A. M. Davies. 1971. Epidemiological aspects of cholera El Tor outbreak in a non-endemic area. Lancet ii:86-89.
63. Colwell, R. R., P. R. Brayton, D. J. Grimes, D. R. Roszak, S. A. Huq, and L. M. Palmer. 1985. Viable, but non-culturable Vibrio cholerae and related pathogens in the environment: implications for release of genetically engineered microorganisms. Bio/Technology 3:817-820.
64. Colwell, R. R., J. A. K. Hasan, A. Huq, L. Loomis, R. J. Siebeling, M. Torres, S. Galvez, S. Islam, and D. Bernstein. 1992. Development and evaluation of a rapid, simple, sensitive, monoclonal antibody-based coagglutination test for direct detection of Vibrio cholerae O1. FEMS Microbiol. Lett. 97:215-220.
65. Colwell, R. R., and A. Huq. 1994. Vibrios in the environment: viable but nonculturable Vibrio cholerae, p. 117-133. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
66. Colwell, R. R., J. Kaper, and S. W. Joseph. 1977. Vibrio cholerae, Vibrio parahaemolyticus and other vibrios: occurrence and distribution in Chesapeake Bay. Science 198:394-396.
67. Colwell, R. R., and W. M. Spira. 1992. The ecology of Vibrio cholerae, p. 107-127. In D. Barua and W. B. Greenough, III (ed.), Cholera. Plenum Medical Book Co., New York.
68. Colwell, R. R., M. L. Tamplin, P. R. Brayton, A. L. Gauzens, B. D. Tall, D. Herrington, M. M. Levine, S. Hall, A. Huq, and D. A. Sack. 1990. Environmental aspects of Vibrio cholerae in transmission of cholera, p. 327-343. In R. B. Sack, and Y. Zinnaka (ed.), Advances in research on cholera and related diarrheas, vol. 7. KTK Scientific Publishers, Tokyo.
69. Cook, W. L., K. Wachsmuth, S. R. Johnson, K. A. Birkness, and A. R. Samadi. 1984. Persistence of plasmids, cholera toxin genes, and prophage DNA in classical Vibrio cholerae O1 Infect. Immun. 45:222-226.
70. Cooke, H. J. 1991. Hormones and neurotransmitters regulating intestinal ion transport, p. 23-48. In M. Field (ed.), Diarrheal diseases. Elsevier. New York.
71. Cray, W. C., Jr., E. Tokunaga, and N. F. Pierce. 1983. Successful colonization and immunization of adult rabbits by oral inoculation with Vibrio cholerae O1. Infect. Immun. 41:735-741.
72. Cryz, S. J., M. M. Levine, J. B. Kaper, E. Purer, and B. Althaus. 1990. Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults. Vaccine 8:577-580.
73. Curlin, G., R. Levine, K. M. A. Aziz, A. S. M. M. Rahman, and W. F. Verwey. 1974. Field trial of cholera toxoid, p. 314-329. In Proceedings of the 11th Joint Conference on Cholera, U.S.-Japan Cooperative Medical Science Program. U.S. Department of Health, Education, and Welfare, Washington. D.C.
74. Czerkinsky, C., M. W. Russell, N. Lycke, M. Lindblad, and J. Holmgren. 1989. Oral administration of a streptococcal antigen coupled to cholera toxin B subunit evokes strong antibody responses in salivary glands and extramucosal tissues. Infect. Immun. 57:1072-1077.
75. De, S. N. 1959. Enterotoxicity of bacteria-free culture filtrate of Vibrio cholerae. Nature (London) 183:1533-1534.
76. Deb, B. C., B. K. Sircar, P. G. Sengupta, S. P. De, S. K. Mondai, D. N. Gupta, N. C. Saha, S. Ghosh, U. Mitra, and S. C. Pal. 1986. Studies on interventions to prevent eltor cholera transmission in urban slums. Bull. W. H. O. 64:127-131.
77. de Jonge, H. R. 1991. Intracellular mechanisms regulating intestinal secretion, p. 107-114. In T. Wadström. P. H. Mäkelä, A.-M. Svennerholm, and H. Wolf-Watz (ed.), Molecular pathogenesis of gastrointestinal infections. Plenum Press, New York.
78. DePaola, A., G. M. Capers, M. L. Motes, O. Olsvik, P. I. Fields, J. Wells, I. K. Wachsmuth, T. A. Cebula, W. H. Koch, F. Khambaty, M. H. Kothary, W. L. Payne, and B. A. Wentz. 1992. Isolation of Latin American epidemic strain of Vibrio cholerae Ol from US Gulf Coast. Lancet 339:624.
79. Dertzbaugh, M. T., D. L. Peterson, and F. L. Macrina. 1990. Cholera toxin B-subunit gene fusion: structural and functional analysis of the chimeric protein. Infect. Immun. 58:70-79.
80. Desmarchelier, P. M., H. Momen, and C. A. Salles. 1988. A zymovar analysis of Vibrio cholerae isolated in Australia. Trans. R. Soc. Trop. Med. Hyg. 82:914-917.
81. Desmarchelier, P. M., and C. R. Senn. 1989. A molecular epidemiological study of V. cholerae in Australia. Med. J. Aust. 150:631-634.
82. Diamond, J. M. 1977. The epithelial junction: bridge, gate and fence. Physiologist 20:10-18.
83. DiRita, V. J. 1992. Co-ordinate expression of virulence genes by ToxR in Vibrio cholerae. Mol. Microbiol. 6:451-458.
84. DiRita, V. J., and J. J. Mekalanos. 1991. Periplasmic interaction between two membrane regulatory proteins, ToxR and ToxS, results in signal transduction and transcriptional activation. Cell 64:29-37.
85. DiRita, V. J., C, Parsot, G. Jander, and J. J. Mekalanos. 1991. Regulatory cascade controls virulence in Vibno cholerae. Proc. Natl. Acad. Sci. USA 88:5403-5407.
86. Dizon, J. J. 1974. Cholera carriers, p. 367-379. In D. Barua and W. Burrows (ed.), Cholera. W. B. Saunders Co., Philadelphia.
87. Dominguez, P., G. Velasco, F. Barros, and P. S. Lozo. 1987. Intestinal brush border membranes contain regulatory subunits of adenylyl cyclase. Proc. Natl. Acad. Sci. USA 84:6965-6969.
88. Donta, S. T. 1974. Differentiation between the steroidogenic effects of cholera enterotoxin and adrenocorticotropin through use of a mutant adrenal cell line. J. Infect. Dis. 129:728-731.
89. Donta, S. T., S. Beristain, and T. K. Tomicic. 1993. Inhibition of heat-labile cholera and Escherichia coli enterotoxins by brefeldin A. Infect. Immun. 61:3282-3286.
90. Dubey, R. S., M. Lindblad, and J. Holmgren. 1990. Purification of El Tor cholera enterotoxins and comparisons with classical toxin. J. Gen. Microbiol. 136:1839-1847.
91. Dutta, N. K., M. W. Panse, and D. R. Kulkarni. 1959. Role of cholera toxin in experimental cholera. J. Bacteriol. 78:594-595.
92. Ehara, M., M. Ishibashi, Y. Ichinose, M. Iwanaga, S. Shimotori, and T. Naito. 1987. Purification and partial characterization of fimbriae of Vibrio cholerae O1 Vaccine 5:283-288.
93. Eubanks, E. R., M. N. Guentzel, and L. J. Berry. 1977. Evaluation of surface components of Vibrio cholerae as protective immunogens. Infect. Immun. 15:533-538.
94. Everiss, K., C. Harkey, K. Hughes, M. Kovach, and K. Peterson. 1992. Molecular analysis of the accessory colonization factor gene cluster of Vibrio cholerae, p. 26. In Abstracts of the 92nd General Meeting of the American Society for Microbiology 1992. American Society for Microbiology, Washington, D.C.
95. Faruque, S. M., L. Comstock, J. B. Kaper, and M. J. Albert. Distribution of zonula occludens toxin (zot) gene among clinical isolates of Vibrio cholerae Ol from Bangladesh and Africa. J. Diarrhoeal Dis. Res., in press.
96. Faruque, S. M., A. R. M. A. Alim, M. M. Rahman, A. K. Siddique, R. B. Sack, and M. J. Albert. 1993. Clonal relationships among classical Vibrio cholerae O1 strains isolated between 1961 and 1992 in Bangladesh. J. Clin. Microbiol. 31:2513-2516.
97. Fasano, A., B. Baudry, D. W. Pumplin, S. S. Wasserman, B. D. Tall, J. M. Ketley, and J. B. Kaper. 1991. Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc. Natl. Acad. Sci. USA 88:5242-5246.
98. Felsenfeld, O. 1965. Notes on food, beverages and fomites contaminated with Vibrio cholerae. Bull. W. H. O. 33:725-734.
99. Field, M. 1971. Intestinal secretion: effect of cyclic AMP and its role in cholera. N. Engl. J. Med. 284:1137-1144.
100. Field, M. 1981. Secretion of electrolytes and water by mammalian small intestine, p. 963-982. In L. R. Johnson (ed.), Physiology of the gastrointestinal tract. Raven Press, New York.
101. Field, M., D. Fromm, Q. Al-Awqati, and W. B. Greenough, III. 1972. Effect of cholera enterotoxin on ion transport across isolated ileal mucosa. J. Clin. Invest. 51:796-804.
102. Field, M., D. Fromm, C. K. Wallace, and W. B. Greenough, III. 1969. Stimulation of active chloride secretion in small intestine by cholera exotoxin. J. Clin. Invest. 48:24a.
103. Field, M., M. C. Rao, and E. B. Chang. 1989. Intestinal electrolyte transport and diarrheal disease, part 2. N. Engl. J. Med. 321:879-883.
104. Fields, P. I., D. N. Cameron, and P. Manning. 1993. The molecular basis for Ogawa-Inaba serotype shift in Vibrio cholerae O1, p. 63-65. In Abstracts of the 28th Joint U.S.-Japan Cooperative Medical Science Program, Cholera Panel. National Institutes of Health, Bethesda, Md.
105. Fields, P. I., T. Popovic, K. Wachsmuth, and Ø. Olsvik. 1992. Use of polymerase chain reaction for detection of toxigenic Vibrio cholerae O1 strains from the Latin American cholera epidemic. J. Clin. Microbiol. 30:2118-2121.
106. Finch, M. J., J. G. Morris, J. Kaviti, W. Kagwanja, and M. M. Levine. 1988. Epidemiology of antimicrobial resistant cholera in Kenya and East Africa. Am. J. Trop. Med. Hyg. 39:484-490.
107. Finelli, L., D. Swerdlow, K. Mertz, H. Ragazzoni, and K. Spitalny. 1992. Outbreak of cholera associated with crab brought from an area with epidemic disease. J. Infect. Dis. 166:1433-1435.
108. Kinkelstein, R. A. 1992. Cholera enterotoxin (choleragen) - a historical perspective, p. 155-187. In D. Barua and W. B. Greenough, III (ed.), Cholera. Plenum Medical Book Co., New York.
109. Finkelstein, R. A., M. Boesman-Finkelstein, Y. Chang, and C. C. Häse. 1992. Vibrio cholerae hemagglutinin/protease, colonial variation, virulence, and detachment. Infect. Immun. 60:472-478.
110. Finkelstein, R. A., M. Boesman-Finkelstein, and P. Holt. 1983. Vibrio cholerae hemagglutinin/lectin/protease hydrolyzes fibronectin and ovomucin: F. M. Burnet revisited. Proc. Nail. Acad. Sci. USA 80:1092-1095.
111. Finkelstein, R. A., and E. H. LaBrec. 1959. Rapid identification of cholera vibrios with fluorescent antibody. J. Bacteriol. 78:886-891.
112. Finkelstein, R. A., and J. J. LoSpalluto. 1969. Pathogenesis of experimental cholera: preparation and isolation of choleragen and choleragenoid. J. Exp. Med. 130:185-202.
113. Finn, T. M., J. Reiser, R. Germanier, and S. J. Cryz, Jr. 1987. Cell-associated hemagglutinin-deficient mutant of Vibrio cholerae. Infect. Immun. 55:942-946.
114. Follett, E. A. C., and J. Gordon. 1963. An electron microscope study of vibrio flagella. J. Gen. Microbiol. 32:235-239.
115. Forrest, B. D., J. T. LaBrooy, S. R. Attridge, G. Boehm, L. Beyer, R. Morona, D. J. C. Shearman, and D. Rowley. 1989. Immunogeniciry of a candidate live oral typhoid/cholera hybrid vaccine in humans. J. Infect. Dis. 159:145-146.
116. M1 induces B cell activation. J. Immunol. 148:1999-2005.
117. Franco, A. A., A. C. Wright, A. Prada, E. Paredes, J. C. Palomino, H. Guerra, and J. G. Morris, Jr. 1994. Enumeration of Vibrio cholerae from water and sewage in Lima, Peru, p. 431. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
118. Franzon, V. L., A. Barker, and P. A. Manning. 1993. Nucleotide sequence encoding the mannose-fucose-resistant hemagglutinin of Vibrio cholerae O1 and construction of a mutant. Infect. Immun. 61:3032-3037.
119. Franzon, V. L., and P. A. Manning. 1986. Molecular cloning and expression in Escherichia coli K-12 of the gene for a hemagglutinin from Vibrio cholerae. Infect. Immun. 52:279-284.
120. Freer, J. H., and T. H. Birkbeck. 1982. Possible conformation of delta-lysin, a membrane-damaging peptide of Staphylococcus aureus. J. Theor. Biol. 94:535-540.
121. Freter, R., B. Allweiss, P. M. C. O'Brien, S. A. Halstead, and M. S. Macsai. 1981. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vitro studies. Infect. Immun. 34:241-249.
122. Freter, R., and G. W. Jones. 1976. Adhesive properties of Vibrio cholerae: nature of the interaction with intact mucosal surfaces. Infect. Immun. 14:246-256.
123. Freter, R., and P. C. M. O'Brien. 1981. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: fitness and virulence of nonchemotactic Vibrio cholerae mutants in infant mice. Infect. Immun. 34:222-233.
124. Freter, R., P. C. M. O'Brien, and M. S. Macsai. 1981. Role of chemotaxis in the association of motile bacteria with intestinal mucosa: in vivo studies. Infect. Immun. 34:234-240.
125. Fuerst, J. A., and J. W. Perry. 1988. Demonstration of lipopolysaccharide on sheathed flagella of Vibrio cholerae O:1 by protein A-gold immunoelectron microscopy. J. Bacteriol. 170:1488-1494.
126. Gaginella, T. S. 1990. Eicosanoid-mediated intestinal secretion, p. 15-30. In E. Lebenthal and M. E. Duffey (ed.), Textbook of secretory diarrhea. Raven Press, New York.
127. Galen, J. E., J. M. Ketley, A. Fasano, S. H. Richardson, S. S. Wasserman, and J. B. Kaper. 1992. Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect. Immun. 60:406-415.
128. Gallut, J. 1974. Bacteriology, p. 17-40. In D. Barua and W. Burrows (ed.), Cholera. W. B. Saunders Co., Philadelphia.
129. Gangarosa, E. J., and W. H. Mosley. 1974. Epidemiology and surveillance of cholera, p. 381-403. In D. Barua and W. Burrows (ed.), Cholera. W. B. Saunders Co., Philadelphia.
130. Gennaro, M. L., P. J. Greenaway, and D. A. Broadbent. 1982. The expression of biologically active cholera toxin in Escherichia coli. Nucleic Acids Res. 10:4883-4890.
131. Gill, D. M., and C. A. King. 1975. The mechanism of action of cholera toxin in pigeon erythrocyte lysates. J. Biol. Chem. 250:6424-6432.
132. Gill, D. M., and R. S. Rappaport. 1979. Origin of the enzymatically active Al fragment of cholera toxin. J. Infect. Dis. 139:674-680.
133. Glass, R. I., S. Becker, M. I. Huq, B. J. Stoll, M. U. Khan, M. H. Merson, J. V. Lee, and R, E. Black. 1982. Endemic cholera in rural Bangladesh, 1966-1980. Am. J. Epidemiol. 116:959-970.
134. Glass, R. I., and R. E. Black. 1992. The epidemiology of cholera, p. 129-154. In D. Barua and W. B. Greenough, III (ed.), Cholera. Plenum Medical Book Co., New York.
135. Glass, R. I., M. Claeson, P. A. Blake, R. J. Waldman, and N. F. Pierce. 1991. Cholera in Africa: lessons on transmission and control for Latin America. Lancet 338:791-795.
136. Glass, R. I., J. Holmgren, C. E. Haley, M. R. Khan, A. M. Svennerholm, B. J. Stoll, K. M. Belayet Hossain, R. E. Black, M. Yunus, and D. Barua. 1985. Predisposition for cholera of individuals with O blood group. Possible evolutionary significance. Am. J. Epidemiol. 121:791-796.
137. Glass, R. I., I. Huq, A. R. M. A. Alim, and M. Yunus. 1980. Emergence of multiply antibiotic-resistant Vibrio cholerae in Bangladesh. J. Infect. Dis. 142:939-942.
138. Glass, R. I, A. M. Svennerholm, M. R. Khan, S. Huda, M. I. Huq, and J. Holmgren. 1985. Seroepidemiological studies of El Tor cholera in Bangladesh: association of serum antibody levels with protection. J. Infect. Dis. 151:236-242.
139. Glass, R. I., A. M. Svennerholm, B. J. Stoll, M. R. Khan, K. M. Hossain, M. I. Huq, and J. Holmgren. 1983. Protection against cholera in breast-fed children by antibodies in breast milk. N. Engl. J. Med. 308:1389-1392.
140. Goldberg, I., and J. J. Mekalanos. 1986. Effect of a recA mutation on cholera toxin gene amplification and deletion events. J. Bacteriol. 165:723-731.
141. Goldberg, M. B., S. A. Boyko, and S. B. Calderwood. 1990. Transcriptional regulation by iron of a Vibrio cholerae virulence gene and homology of the gene to the Escherichia coli Fur system. J. Bacteriol. 172:6863-6870.
142. Goldberg, M. B., S. A. Boyko, and S. B. Calderwood. 1991. Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 88:1125-1129.
143. Goldberg, M. B., V. J. DiRita. and S. B. Calderwood. 1990. Identification of an iron-regulated virulence determinant in Vibrio cholerae, using TnphoA mutagenesis. Infect. Immun. 58:55-60.
144. Goldberg, S., and J. R. Murphy. 1983. Molecular epidemiological studies of United States Gulf Coast Vibrio cholerae strains: integration site of mutator vibriophage VcA-3. Infect. Immun. 42:224-230.
145. Goodgame, R. W., and W. B. Greenough, III. 1975. Cholera in Africa: a message for the West. Ann. Intern. Med. 82:101-106.
146. Greenough, W., III, A. S. Beneson, and M. R. Islam. 1965. Experience of darkfield examination of stools from diarrheal patients, p. 56-58. In Proceedings of the Cholera Research Symposium (Jan. 24-29, 1965, Honolulu). U.S. Government Printing Office, Washington, D.C.
147. Griffiths, G. L., S. P. Sigel, S. M. Payne, and J. B. Neilands. 1984. Vibriobactin, a siderophore from Vibrio cholerae. 3. Biol. Chem. 259:383-385.
148. Griffiths, S. L., R. A. Finkelstein, and D. R. Critchley. 1986. Characterization of the receptor for cholera toxin and Escherichia coli heat-labile toxin in rabbit intestinal brush borders. Biochem. J. 238:313-322.
149. Guentzel, M. N., and L. J. Berry. 1975. Motility as a virulence factor for Vibrio cholerae. Infect. Immun. 11:890-897.
150. Guerrant, R. L., L. L. Brunton, T. C. Schnaitman, L. I. Rebhun, and A. G. Gilman. 1974. Cyclic adenosinc monophosphate and alteration of Chinese hampster ovary cell morphology: a rapid, sensitive in vitro assay for the enterotoxins of Vibrio cholerae and Escherichia coli. Infect. Immun. 10:320-327.
151. Gustafsson, B., and T. Holme. 1985. Rapid detection of Vibrio cholerae O:1 by motility inhibition and immunofluorescence with monoclonal antibodies. Eur. J. Clin. Microbiol. 4:291-294.
152. Hall, R. H., E. M. Khambaty, M. Kothary, and S. P. Keasler. 1993. Non-O1 Vibrio cholerae. Lancet 342:430.
153. Hall, R. H., G. Losonsky, A. P. Silveira, R. K. Taylor, J. J. Mekalanos, N. D. Witham, and M. M. Levine. 1991. Immunogenicity of Vibrio cholerae O1 roxin-coregulated pili in experimental and clinical cholera. Infect. Immun. 59:2508-2512.
154. Hall, R. H., P. A. Vial, J. B. Kaper, J. J. Mekalanos, and M. M. Levine. 1988. Morphological studies on fimbriae expressed by Vibrio cholerae O1 Microb. Pathog. 4:257-265.
155. Hanne, L. F., and R. A. Finkelstein. 1982. Characterization and distribution of the hemagglutinins produced by Vibrio cholerae. Infect. Immun. 36:209-214.
156. Hasan, J. A. K., A. Huq, M. L. Tamplin, R. J. Siebeling, and R. R. Colwell. 1994. A novel kit for rapid detection of Vibrio cholerae O1. J. Clin. Microbiol. 32:249-252.
157. Hase, C. C., M. E. Bauer, and R. A. Finkelstein. 1993. Genetic characterization of MSHA-negative mutants of Vibrio cholerae derived by Tn5 mutagenesis, p. 84. In Abstracts of the 93rd General Meeting of the American Society for Microbiology 1993. American Society for Microbiology, Washington, D.C.
158. Hase, C. C., and R. A. Finkelstein. 1991. Cloning and nucleotide sequence of the Vibrio choleras hemagglutinin/protease (HA/protease) gene and construction of an HA/protease-negative strain. J. Bacteriol. 173:3311-3317.
159. Hecht, G., C. Pothoulakis, J. T. LaMont, and J. L. Madara. 1988. Clostridium difficile toxin A perturbs cytoskeletal structure and tight junction permeability of the cultured human. J. Clin. Invest. 82:1516-1524.
160. Hedges, R. W., J. L. Vialard, N. J. Pearson, and F. O'Grady. 1977. R plasmids from Asian strains of Vibrio cholerae. Antimicrob. Agents Chemother. 11:585-588.
161. Heiberg, B. 1936. The biochemical reaction of vibrios. J. Hyg. 36:114-117.
162. Henderson, D. P., and S. M. Payne. 1993. Cloning and characterization of the Vibrio cholerae genes encoding the utilization of iron from haemin and haemoglobin. Mol. Microbiol. 7:461-469.
163. Hepler, J. R., and A. G. Gilman. 1992. G proteins. Trends Biochem. Sci. 17:383-387.
164. Herrington, D. A., R. H. Hall, G. Losonsky, J. J. Mekalanos, R. K. Taylor, and M. M. Levine. 1988. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J. Exp. Med. 168:1487-1492.
165. Higgins, D. E., E. Nazareno, and V. J. DiRita. 1992. The virulence gene activator ToxT from Vibrio cholerae is a member of the AraC family of transcriptional activators. J. Bacteriol. 174:6974-6980.
166. Hirst, T. R. 1991. Assembly and secretion of oligomeric toxins by Gramnegative bacteria, p. 75-100. In J. E. Alouf and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press, Ltd., London.
167. Hoge, C. W., O. Sethabutr, L. Bodhidatta, P. Echeverria, D. C. Robertson, and J. G. Morris, Jr. 1990. Use of a synthetic oligonucleotide probe to detect strains of non-serovar Ol Vibrio cholerae carrying the gene for heat-stable enterotoxin (NAG-ST). J. Clin. Microbiol. 28:1473-1476.
168. Holmberg, S. D., J. R. Harris, D. E. Kay, N. T. Hargrett, R. D. R. Parker, N. Kansou, N. U. Rao, and P. A. Blake. 1984. Foodborne transmission of cholera in Micronesian households. Lancet i:325-328.
169. Holmgren, J. 1992. Pathogenesis. p. 199-208. In D. Barua and W. B. Greenough, III (ed.), Cholera. Plenum Medical Book Co., New York.
170. M1 ganglioside of small intestine. Proc. Natl. Acad. Sci. USA 72:2520-2524.
171. Holmgren, J., N. Lycke, and C. Czerkinsky. 1993. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems. Vaccine 11:1179-1184.
172. Holmgren, J., J. Osek, and A.-M. Svennerholm. 1994. Protective oral cholera vaccine based on a combination of cholera toxin B subunit and inactivated cholera vibrios, p. 415-424. In I. K. Wachsmuth, P. A. Blake, and 0. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
173. Holmgren, J., and A. M. Svennerholm. 1977. Mechanisms of disease and immunity in cholera: a review. J. Infect. Dis. 136(Suppl.):S105-S112.
174. Honda, T., and R. A. Finkelstein. 1979. Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera enterotoxin. Proc. Natl. Acad. Sci. USA 76:2052-2056.
175. Honda, T., and R. A. Finkelstein. 1979. Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios. Infect. Immun. 26:1020-1027.
176. Honda, T., M. Nishibuchi, T. Miwalani, and J. B. Kaper. 1986. Demonstration of a plasmid-borne gene encoding a thermostable direct hemolysin in Vibrio cholerae non-O1 strains. Appl. Environ. Microbiol. 52:1218-1220.
177. Hood, M. A., J. B. Guckert, D. C. White, and F. Deck. 1986. Effect of nutrient deprivation on lipid, carbohydrate, DNA, RNA, and protein levels in Vihno cholerae. Appl. Environ. Microbiol. 52:788-793.
178. Hranitsky, K. W., A. Mulholland, A. D. Larson, et al. 1980. Characterization of a flagellar sheath protein of Vibrio cholerae. Infect. Immun. 27:597-603.
179. Hranitzky, K. W., A. Mulholland, A. D. Larson, E. R. Eubanks, and L. T. Hart. 1980. Characterization of a flagellar sheath protein of Vibrio cholerae. Infect. Immun. 27:597-603.
180. Hughes, J. M., J. M. Boyce, R. J. Levine, M. Khan, K. M. A. Aziz, M. I. Huq, and G. T. Curlin. 1982. Epidemiology of eltor cholera in rural Bangladesh: importance of surface water in transmission. Bull. W. H. O. 60:395-404.
181. Hughes, J. M., D. G. Hollis, E. J. Gangarosa, and R. E. Weaver. 1978. Non-cholera vibrio infections in the United States. Ann. Intern. Med. 88:602-606.
182. Huq, A., E. B. Small, P. A. West, M. I. Huq, R. Rahman, and R. R. Colwell. 1983. Ecological relationships between Vibrio cholerae and planktonic crustacean copepods. Appl. Environ. Microbiol. 45:275-283.
183. Ichinose, Y., K. Yamamoto, N. Nakasone, M. J. Tanabe, T. Takeda, T. Miwatani, and M. Iwanaga. 1987. Enterotoxicity of El Tor-like hemolysin of non-O1 Vibrio cholerae. Infect. Immun. 55:1090-1093.
184. Iredell, J. R., and P. A. Manning. 1994. Biotype-specific tcpA genes in Vibrio cholerae. FEMS Microbiol. Lett. 121:47-54.
185. Islam, M. S., M. K. Hasan, M. A. Miah, F. Qadri, M. Yunus, R. B. Sack, and M. J. Albert. 1993. Isolation of Vibrio cholerae O139 Bengal from water in Bangladesh. Lancet 342:430.
186. Ito, T., K. Hiramatsu, Y. Ohshita, and T. Yokota. 1993. Mutations in the rfbT gene are responsible for the Ogawa to Inaba serotype conversion in Vibrio choleras Ol. Microbiol. Immunol. 37:281-288.
187. Jacob, A., V. B. Sinha, M. K. Sahib, R. Srivastava, J. B. Kaper, and B. S. Srivastava. 1993. Identification of a 33 kDa antigen associated with an adhesive and colonizing strain of Vibno cholerae El Tor and its role in protection. Vaccine 11:376-382.
188. Jalajakumari, M. B., and P. A. Manning. 1990. Nucleotide sequence of the gene, ompW, encoding a 22kDa immunogenic outer membrane protein of Vibrio cholerae. Nucleic Acids Res. 18:2180.
189. Janicot, M., F. Fouque, and B. Desbuquois. 1991. Activation of rat liver adenylate cyclase by cholera toxin requires toxin internalization and processing in endosome. J. Biol. Chem. 266:12858-12865.
190. Jesudason, M. V., A. M. Cherian, and T. J. John. 1993. Blood stream invasion by Vibrio cholerae O139. Lancet 342:431.
191. Jesudason, M. V., C. P. Thangavelu, and M. K. Lalitha. 1984. Rapid screening of fecal samples for Vibrio cholerae by a coagglutination technique. J. Clin. Microbiol. 19:712-713.
192. Johnson, J. A., R. J. Hopkins, P. Panigrahi, and J. G. Morris, Jr. 1993. Evidence that the polysaccharide capsule of the non-O1 Vibrio cholerae NRT-36S mediates attachment to epithelial cells, p. 83 In Abstracts of the 93rd General Meeting of the American Society for Microbiology 1993. American Society for Microbiology, Washington, D.C.
193. Johnson, J. A., J. G. Morris, Jr., and J. B. Kaper. 1993. Gene encoding zonula occludens toxin (zot) does not occur independently from cholera enterotoxin genes (ctx) in Vibrio cholerae. J. Clin. Microbiol. 31:732-733.
194. Johnson, J. A., P. Panigrahi, and J. G. Morris, Jr. 1992. Non-O1 Vibrio cholerae NRT36S produces a polysaccharide capsule that determines colony morphology, serum resistance, and virulence in mice. Infect. Immun. 60:864-869.
195. Johnson, J. A., C. A. Salles, P. Panigrahi, M. J. Albert, A. C. Wright, R. J. Johnson, and J. G. Morris, Jr. 1994. Vibrio cholerae O139 synonym Bengal is closely related to Vibrio cholerae El Tor but has important differences. Infect. Immun. 62:2108-2110.
196. Johnston, J. M., D. L. Martin, J. Perdue, L. M. McFarland, C. T. Caraway, E. C. Lippy, and P. A. Blake. 1983. Cholera on a Gulf Coast oil rig. N. Engl. J. Med. 309:523-526.
197. Jones, G. W., and R. Freter. 1976. Adhesive properties of Vibrio cholerae: nature of the interaction with isolated rabbit brush border membranes and human erythrocytes. Infect. Immun. 14:240-245.
198. Jonson, G., J. Holmgren, and A.-M. Svennerholm. 1991. Identification of a mannose-binding pilus on Vibno cholerae El Tor. Microb. Pathog. 11:433-441.
199. Jonson, G., J. Holmgren, and A.-M. Svennerholm. 1991. Epitope differences in toxin-coregulated pili produced by classical and El Tor Vibrio cholerae Ol. Microb. Pathog. 11:179-188.
200. Jonson, G., J. Holmgren, and A.-M. Svennerholm. 1992. Analysis of expression of toxin-coregulated pili in classical and El Tor Vibrio cholerae O1 in vitro and in vivo. Infect. Immun. 60:4278-4284.
201. Jonson, G., M. Lebens, and J. Holmgren. 1994. Cloning and sequencing of Vibrio cholerae mannose-sensitive haemagglutinin pilin gene: localization of mshA within a cluster of type 4 pilin genes. Mol. Microbiol. 13:109-118.
202. Jonson, G., A.-M. Svennerholm, and J. Holmgren. 1989. Vibrio cholerae expresses cell surface antigens during intestinal infection which are not expressed during in vitro culture. Infect. Immun. 57:1809-1815.
203. Jonson, G., A.-M. Svennerholm, and J. Holmgren. 1990. Expression of virulence factors by classical and El Tor Vibrio cholerae in vivo and in vitro. FEMS Microbiol. Ecol. 74:221-228.
204. S promotes dissociation of its a and b subunits. J. Biol. Chem. 259:6235-6240.
205. Kamal, A. M. 1974. The seventh pandemic of cholera, p. 1-14. In D. Barua and W. Burrows (ed.), Cholera. W. B. Saunders, Philadelphia.
206. Kaper, J., H. Lockman, R. R. Colwell, and S. W. Joseph. 1979. Ecology, serology, and enterotoxin production of Vibrio cholerae in Chesapeake Bay. Appl. Environ. Microbiol. 37:91-103.
207. Kaper, J. B., H. B. Bradford, N. C. Roberts, and S. Falkow. 1982. Molecular epidemiology of Vibrio cholerae in the U.S. Gulf Coast. J. Clin. Microbiol. 16:129-134.
208. Kaper, J. B., A. Fasano, and M. Trucksis. 1994. Toxins of Vibrio cholerae, p. 145-176. In I. K. Wachsmuth, P. Blake, and 0. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
209. Kaper, J. B., and M. M. Levine. 1981. Cloned cholera enterotoxin genes in study and prevention of cholera. Lancet ii:1162-1163.
210. Kaper, J. B., H. Lockman, M. M. Baldini, and M. M. Levine. 1984. A recombinant live oral cholera vaccine. Bio/Technology 2:345-349.
211. Kaper, J. B., H. Lockman, M. M. Baldini, and M. M. Levine. 1984. Recombinanf nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature (London) 308:655-658.
212. Kaper, J. B., H. L. T. Mobley, J. M. Michalski, D. A. Herrington, and M. M. Levine. 1988. Recent advances in developing a safe and effective live oral attenuated Vibrio cholerae vaccine, p. 161-167. In N. Ohtomo and R. B. Sack (ed.), Advances in research on cholera and related diarrheas, vol. 6. KTK Scientific Publishers, Tokyo.
213. Kaper, J. B., S. L. Moseley, and S. Falkow. 1981. Molecular characterization of environmental and nontoxigenic strains of Vibrio cholerae. Infect. Immun. 32:661-667.
214. Kaper, J. B., J. P. Nataro, N. C. Roberts, R. J. Siebeling, and H. B. Bradford. 1986. Molecular epidemiology of non-O1 Vibrio cholerae and Vibrio mimicus in the U.S. Gulf Coast region. J. Clin. Microbiol. 23:652-654.
215. Kapral, F. A., A. D. O'Brien, P. D. Ruff, and W. J. Drugan, Jr. 1976. Inhibition of water absorption in the intestine by Staphylococcm aureus delta-toxin. Infect. Immun. 13:140-145.
216. Karasawa, T., T. Mihara, H. Kurazono, G. B. Nair, S. Garg, T. Ramamurthy, and Y. Takeda. 1993. Distribution of the zot (zonula occludens toxin) gene among strains of Vibrio cholerae Ol and non-O1. FEMS Microbiol. Lett. 106:143-146.
217. Kaufman, M. R., C. E. Shaw, I. D. Jones, and R. K. Taylor. 1993. Biogenesis and regulation of the Vibrio cholerae toxin-coregulated pilus: analogies to other virulence factor secretory systems. Gene 126:43-49.
218. Keasler, S. P., and R. H. Hall. 1993. Detecting and biotyping Vibrio cholerae Ol with multiplex polymerase chain reaction. Lancet 341:1661.
219. Kelly, M. T., F. W. Hickman-Brenner, and J. J. Farmer, III. 1991. Vibrio, p. 384-395. In A. Balows, W. J. Hausler, Jr., K. O. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
220. Kenne, L., B. Lindberg, P. Unger, B. Gustafsson, and T. Holme. 1982. Structural studies of the Vibrio cholerae O-antigen. Carbohydr. Res. 100: 341-349.
221. Ketley, J. M., J. Michalski, J. Galen, M. M. Levine, and J. B. Kaper. 1993. Construction of genetically-marked Vibrio cholerae O1 vaccine strains. FEMS Microbiol. Lett. 111:15-22.
222. Kitnberg, D. K., M. Field, J. Johnson, E. Henderson, and E. Gershon. 1971. Stimulation of intestinal mucosal adenyl cyclase by cholera enterotoxin and prostaglandins. J. Clin. Invest. 50:1218-1230.
223. King, C. A., and W. E. van Heyningen. 1973. Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside. J. Infect. Dis. 127:639-647.
224. Klontz, K. C., R. V. Tauxe, W. L. Cook, W. H. Riley, and I. K. Wachsmuth. 1987. Cholera after the consumption of raw oysters. Ann. Intern. Med. 107:846-848.
225. Koblavi, S., F. Grimont, and P. A. D. Grimont. 1990. Clonal diversity of Vibrio cholerae Ol evidenced by rRNA gene restriction patterns. Res. Microbiol. 141:645-657.
226. Koch, R. 1883. Der zweite Bericht der deutschen Cholera-Commission. Dtsch. Med. Wochenschr. 9:743-744.
227. Koch, R. 1884. An address on cholera and its bacillus. Br. Med. J. 1884:403-407.
228. Koch, W. H., W. L. Payne, B. A. Wentz, and T. A. Cebula. 1993. Rapid polymerase chain reaction method for detection of Vibrio cholerae in foods. Appl. Environ. Microbiol. 59:556-560.
229. Kolvin, J. L., and D. Roberts. 1982. Studies on the growth of Vibrio cholerae biotype eltor and biotype classical in foods. J. Hyg. Camb. 89:243-252.
230. Koonin, E. V. 1992. The second cholera toxin, Zot, and its plasmid-encoded and phage-encoded homologues constitute a group of putative ATPases with an altered purine NTP-binding motif. FEBS Lett. 312:3-6.
231. Kotloff, K. L., S. S. Wasserman, S. O'Donnell, G. A. Losonsky, S. J. Cryz, and M. M. Levine. 1992. Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial. Infect. Immun. 60:4430-4432.
232. Krause, M., C. Roudier, J. Fierer, J. Harwood, and D. Guiney. 1991. Molecular analysis of the virulence locus of the Salmonella dublin plasmid pSDL2. Mol. Microbiol. 5:307-316.
233. Lang, H., and E. T. Palva. 1993. The ompS gene of Vibrio cholerae encodes a growth-phase-dependent maltoporin. Mol. Microbiol. 10:891-901.
234. Lang, H. A., and E. T. Palva. 1987. A major outer membrane protein in Vibrio cholerae is maltose-inducible. Microb. Pathog. 3:143-147.
235. Latta, T. 1832. Relative to the treatment of cholera by the copious injection of aqueous and saline fluids into the veins. Lancet ii:274-277.
236. Laval, E. 1989. El cólera en Chile (1886-1888). Rev. Chil. Infect. 6:96-99.
237. Lebens, M., S. Johansson, J. Osek, M. Lindblad, and J. Holmgren. 1993. Large-scale production of Vibrio cholerae toxin B subunit for use in oral vaccines. Bio/Technology 11:1574-1578.
238. 1 peptide generation. J. Clin. Invest. 92:2941-2951.
239. Lencer, W. L, C. Delp, M. R. Neutra, and J. L. Madara. 1992. Mechanism of cholera toxin action on a polarized human intestinal epithelial cell line: role of vesicular traffic. J. Cell Biol. 117:1197-1209.
240. Lesmana, M., D. Subekti, P. Tjaniadi, and G. Pazzaglia. 1994. Modified CAMP test for hiogrouping Vibrio cholerae O1 strains and distinguishing them from strains of V. cholerae non-O1. J. Clin. Microbiol. 32:235-237.
241. Levine, M. M. 1980. Immunity to cholera as evaluated in volunteers, p. 195-203. In O. Ouchterlony and J. Holmgren (ed.), Cholera and related diarrheas. Karger, Basel.
242. Levine, M. M. 1991. South America: the return of cholera. Lancet 338:45-46.
243. Levine, M. M., R, E. Black, M. L. Clements, L. Cisneros, D. R. Nalin, and C. R. Young. 1981. Duration of infection-derived immunity to cholera. J. Infect. Dis. 143:818-820.
244. Levine, M. M., R. E. Black, M. L. Clements, L. Cisneros, A. Saah, D. R. Nalin, D. M. Gill, J. P. Craig, C. R. Young, and P. Ristaino. 1982. The pathogenicity of nonenterotoxigenic Vibno cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil. J. Infect. Dis. 145:296-299.
245. Levine, M. M., R. E. Black, M. L. Clements, C. Lanata, S. Sears, T. Honda, C. R. Young, and R. A. Finkelstein. 1984. Evaluation in humans of attenuated Vibno cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine. Infect. Immun. 43:515-522.
246. Levine, M. M., R. E. Black, M. L. Clements, D. R. Nalin, L. Cisneros, and R. A. Finkelstein. 1981. Volunteer studies in development of vaccines against cholera and enterotoxigenic Escherichia coli: a review, p. 443-459. In T. Holme, J. Holmgren, M. H. Merson, and R. Mollby (ed.), Acute enteric infections in children. New prospects for treatment and prevention. Elsevier/North-Holland Biomedical Press, Amsterdam.
247. Levine, M. M., R. E. Black, M. L. Clements, C. R. Young, C. P. Cheney, P. Schad, H. Collins, and E. C. Boedeker. 1984. Prevention of enterotoxigenic Escherichia coli diarrheal infection in man by vaccines that stimulate anti-adhesion (anti-pili) immunity, p. 223-244. In E. C. Boedeker (ed.), Attachment of organisms to the gut mucosa, vol. 2. CRC Press, Inc., Boca Raton, Fla.
248. Levine, M. M., and J. B. Kaper. 1993. Live oral vaccines against cholera: an update. Vaccine 11:207-212.
249. Levine, M. M., J. B. Kaper, R. E. Black, and M. L. Clements. 1983. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:510-550.
250. Levine, M. M., J. B. Kaper, D. Herrington, J. Ketley, G. Losonsky, C. O. Tacket, B. Tall, and S. Cryz. 1988. Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR. Lancet ii:467-470.
251. Levine, M. M., J. B. Kaper, D. Herrington, G. Losonsky, J. G. Morris, M. L. Clements, R. E. Black, B. Tall, and R. Hall. 1988. Volunteer studies of deletion mutants of Vibrio cholerae Ol prepared by recombinant techniques. Infect. Immun. 56:161-167.
252. Levine, M. M., D. R. Nalin, J. P. Craig, D. Hoover, E. J. Bergquist, D. Waterman, H. P. Holley, R. B. Hornick, N. P. Pierce, and J. P. Libonati. 1979. Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity. Trans. R. Soc. Trop. Med. Hyg. 73:3-9.
253. Levine, M. M., D. R. Nalin, M. B. Rennels, R. B. Hornick, S. Sotman, G. Van Blerk, T. P. Hughes, S. O'Donnell, and D. Barua. 1979. Genetic susceptibility to cholera. Ann. Hum. Biol. 6:369-374.
254. Levine, M. M., and N. F. Pierce. 1992. Immunity and vaccine development, p. 285-327. In D. Barua and W. B. Greenough, III (ed.), Cholera. Plenum Medical Book Co., New York.
255. Levine, M. M., and C. O. Tacket. 1994. Recombinant live cholera vaccines, p. 395-413. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
256. Levine, M. M., C. R. Young, R. E. Black, Y. Takeda, and R. A. Finkelstein. 1985. Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology. J. Clin. Microbiol. 21:174-179.
257. Levine, M. M., C. R. Young, T. P. Hughes, S. ODonnell, R. E. Black, M. L. Clements, R. Robins Browne, and Y. L. Lim. 1981. Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology. Am. J. Epidemiol. 114:348-354.
258. Lin, F. Y., J. G. Morris, Jr., J. B. Kaper, T. Gross, J. Michalski, C. Morrison, J. P. Libonati, and E. Israel. 1986. Persistence of cholera in the United States: isolation of Vibrio cholerae O1 from a patient with diarrhea in Maryland. J. Clin. Microbiol. 23:624-626.
259. Lockman, H., and J. B. Kaper. 1983. Nucleotide sequence analysis of the A2 and B subunits of Vibrio cholerae enterotoxin. J. Biol. Chem. 258:13722-13726.
260. Lockman, H. A., J. E. Galen, and J. B. Kaper. 1984. Vibrio cholerae enterotoxin genes: nucleotide sequence analysis of DNA encoding ADP-ribosyltransferase. J. Bacteriol. 159:1086-1089.
261. Lowry, P. W., A. T. Pavia, L. M. McFarland, B. H. Peltier, T. J. Barrett, H. B. Bradford, J. M. Quan, J. Lynch, J. B. Mathison, R. A. Gunn, and P. A. Blake. 1989. Cholera in Louisiana: widening spectrum of seafood vehicles. Arch. Intern. Med. 149:2079-2084.
262. Lundgren, O. 1988. Factors controlling absorption and secretion in the small intestine, p. 97-112. In W. Donachie, E. Griffiths, and J. Stephen (ed.), Bacterial infections of respiratory and gastrointestinal mucosae. IRL Press, Oxford.
263. Lycke, N., and J. Holmgren. 1986. Strong adjuvant properties of cholera toxin on gut mucosal immune responses to orally presented antigens. Immunology 59:301-308.
264. Lycke, N., U. Karlsson, A. Sjölander, and K.-E. Magnusson. 1991. The adjuvant action of cholera toxin is associated with an increased intestinal permeability for luminal antigens. Scand. J. Immunol. 33:691-698.
265. Lycke, N., and W. Strober. 1989. Cholera toxin promotes B cell isotype differentiation. J. Immunol. 142:3781-3787.
266. Lycke, N., T. Tsuji, and J. Holmgren. 1992. The adjuvant effect of Vibrio cholerae and Eschenchia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity. Eur. J. Immunol. 22:2277-2281.
267. Lycke, N. Y., and A.-M. Svennerholm. 1990. Presentation of immunogens at the gut and other mucosal surfaces, p. 207-227. In G. C. Woodrow and M. M. Levine (ed.), New generation vaccines. Marcel Dekker, Inc., New York.
268. Madara, J. L. 1989. Loosening tight junctions - lessons from the intestine. J. Clin. Invest. 83:1089-1094.
269. Manning, P. A. 1991. Molecular analysis of potential adhesions of Vibrio choleme O1, p. 139-146. In T. Wadström, P. H. Mäkelä, A.-M. Svennerholm, and H. Wolf-Watz (ed.), Molecular pathogenesis of gastrointestinal infections. Plenum Press, New York.
270. Manning, P. A., U. H. Stroeher, and R. Morona. 1994. Molecular basis for O-antigen biosynthesis in Vibno cholerae O1 : Ogawa-Inaba switching, p. 77-94. In I. K. Wachsmuth, P. Blake, and 0. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
271. Manoil, C., and J. Beckwith. 1985. TnphoA: a transposon probe for protein export signals. Proc. Natl. Acad. Sci. USA 82:8129-8133.
272. Mathias, J. R., G. M. Carlson, A. J. DiMarino, G. Bertiger, H. E. Moton, and S. Cohen. 1976. Intestinal myoelectric activity in response to live Vibrio cholerae and cholera enterotoxin. J. Clin. Invest. 58:91-96.
273. McCardell, B., J. M. Madden, and D. B. Shah. 1985. Isolation and characterization of a cytolysin produced by Vibrio cholerae serogroup non-O1. Can. J. Microbiol. 31:711-720.
274. McCormack, W. M., A. M. Chowdhury, N. Jahangir, A. B. Fariduddin Ahmed, and W. H. Mosley. 1968. Tetracycline prophylaxis in families of cholera patients. Bull. W. H. O. 38:787-792.
275. Mekalanos, J. J. 1983. Duplication and amplification of toxin genes in Vibrio cholerae. Cell 35:253-263.
276. Mekalanos, J. J. 1985. Cholera toxin: genetic analysis, regulation, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 118:97-118.
277. Mekalanos, J. J., D. J. Swartz, G. D. Pearson, N. Harford, F. Groyne, and M. de Wilde. 1983. Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine development. Nature (London) 306:551-557.
278. Michalski, J., J. E. Galen, A. Fasano, and J. B. Kaper. 1993. Vibrio cholerae CVD110: a live oral attenuated El Tor vaccine strain. Infect. Immun. 61:4462-4468.
279. Michalski, J. M., and J. B. Kaper. Unpublished data.
280. Miller, C. J., R. G. Feachem, and B. S. Drasar. 1985. Cholera epidemiology in developed and developing countries: new thoughts on transmission, seasonality, and control. Lancet ii:261-263.
281. Miller, J. F., J. J. Mekalanos, and S. Falkow. 1989. Coordinate regulation and sensory transduction in the control of bacterial virulence. Science 243:916-922.
282. Miller, V. L., and J. J. Mekalanos. 1984. Synthesis of cholera toxin is positively regulated at the transcriptional level by toxR. Proc. Natl. Acad. Sci. USA 81:3471-3475.
283. Miller, V. L., and J. J. Mekalanos. 1988. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J. Bacteriol. 170:2575-2583.
284. Miller, V. L., R. K. Taylor, and J. J. Mekalanos. 1987. Cholera toxin transcriptional activator toxR is a transmembrane DNA binding protein. Cell 48:271-279.
285. Miller-Podraza, H., R. M. Bradley, and P. H. Fishman. 1982. Biosynthesis and localization of gangliosides in cultured cells. Biochemistry 21:3260-3265.
286. Minami, A., S. Hashimoto, H. Abe, M. Arita, T. Taniguchi, T. Honda, T. Miwatani, and M. Nishibuchi. 1991. Cholera enterotoxin production in Vibrio cholerae O1 strains isolated from the environment and from humans in Japan. Appl. Environ. Microbiol. 57:2152-2157.
287. Momen, H., and C. A. Salles. 1985. Enzyme markers for Vibrio cholerae: identification of classical, El Tor and environmental strains. Trans. R. Soc. Trop. Med. Hyg. 79:773-776.
288. Monsur, K. A. 1963. Bacteriological diagnosis of cholera under field conditions. Bull. W. H. O. 28:387-389.
289. Morris, J. G., Jr., R. E. Black. 1985. Cholera and other vibrioses in the United States. N. Engl. J. Med. 312:343-350.
290. Morris, J. G., Jr. 1990. Non-O group 1 Vibrio cholerae: a look at the epidemiology of an occasional pathogen. Epidemiol. Rev. 12:179-191.
291. Morris, J. G., Jr. 1994. Cholera and other vibrioses, p. 753-762. In P. D. Hoeprich, M. C. Jordan, and A. R. Ronald (ed.), Infectious diseases: a treatise of infectious processes. J. B. Lippincott Co., Philadelphia.
292. Morris, J. G., Jr., J. A. Johnson, E. W. Rice, C. O. Tacket, G. A. Losonsky, M. B. Sztein, and J. P. Nataro. 1993. Vibrio cholerae O1 can assume a rugose survival form which resists chlorination, but retains virulence for humans, p. 177-182. In Abstracts of the Twenty-ninth Joint Conference on Cholera and Related Diarrheal Diseases. National Institutes of Health, Bethesda, Md.
293. Morris, J. G., Jr., G. Losonsky, C. O. Tacket, and M. M. Levine. Unpublished observations.
294. Morris, J. G., Jr., J. L. Picardi, S. Lieb, J. V. Lee, A. Roberts, M. Hood, R. A. Gunn, and P. A. Blake. 1984. Isolation of nontoxigenic Vibrio cholerae O Group 1 from a patient with severe gastrointestinal disease. J. Clin. Microbiol. 19:296-297.
295. Morris, J. G., Jr., T. Takeda, B. D. Tall, G. A. Losonsky, S. K. Bhattacharya, B. D. Forrest, B. A. Kay, and M. Nishibuchi. 1990. Experimental non-O group 1 Vibrio cholerae gastroenteritis in humans. J. Clin. Invest. 85:697-705.
296. Morris, J. G., Jr., J. H. Tenney, and G. L. Drusano. 1985. In vitro susceptibility of pathogenic Vibrio species to norfloxacin and six other antimicrobial agents. Antimicrob. Agents Chemother. 28:442-445.
297. Morris, J. G., Jr., R. Wilson, B. R. Davis, I. K. Wachsmuth, C. F. Riddle, H. G. Wathen, R. A. Pollard, and P. A. Blake. 1981. Non-O group 1 Vibrio cholerae gastroenteritis in the United States. Ann. Intern. Med. 94:656-658.
298. Moseley, S. L., and S. Falkow. 1980. Nucleotide sequence homology between the heat-labile enterotoxin gene of Escherichia coli and Vibrio cholerae. J. Bacteriol. 144:444-446.
299. Mosley, W. H. 1969. The role of immunity in cholera. A review of epidemiological and serological studies. Tex. Rep. Biol. Med. 27:227-244.
300. Mosley, W. H., W. M. McCormack, and A. Ahmed. 1969. Report of the 1966-67 cholera field trial in rural East Pakistan. 2. Results of the serological surveys in the study population-the relationship of case rate to antibody titre and an estimate of the inapparent infection rate with Vibrio cholerae. Bull. W. H. O. 40:187-197.
301. Mosley, W. H., W. E. Woodward, K. M. S. Azia, et al. 1970. The 1968-1969 cholera vaccine field trial in rural East Pakistan. Effectiveness of monovalent Ogawa and Inaba vaccines and a purified Inaba antigen, with comparative results of serological and animal protection tests. J. Infect. Dis. 121:S1-S9.
302. Moss, J., and M. Vaughan. 1977. Mechanism of activation of choleragen. Evidence for ADP-ribosyltransferase activity with arginine as an acceptor. J. Biol. Chem. 252:2455-2457.
303. Moss, J., and M. Vaughan. 1991. Activation of cholera toxin and Escherichia coli heat-labile enterotoxins by ADP-ribosylation factors, a family of 20-kDa guanine nucleotide-binding proteins. Mol. Microbiol. 5:2621-2627.
304. Mostow, P., and K. Richardson. 1990. High-frequency spontaneous mutation of classical Vibrio cholerae to a nonmotile phenotype. Infect. Immun. 58:3633-3639.
305. Motes, M. L., Jr., S. R. Zywno, A. DePaola, R. E. Becker, and M. W. Presnell. 1983. Isolation of Vibrio cholerae serotype Ogawa from a Florida estuary. Appl. Environ. Microbiol. 45:321-322.
306. Mukerjee, S. 1963. Bacteriophage typing of cholera. Bull. W. H. O. 28:337-345.
307. Munoz, E., A. M. Zubiaga, M. Merrow, N. P. Sauter, and B. T. Huber. 1990. Cholera toxin discriminates between T helper 1 and T helper 2 cells in T cell receptor mediated activation: role of cAMP in T cell proliferation. J. Exp. Med. 172:95-103.
308. Nair, G. B., and Y. Takeda. 1994. Detection of toxins of Vibrio cholerae O1 and non-O1, p. 53-67. In I. K. Wachsmuth, P. A. Blake, and 0. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
309. Nakasone, N., and M. Iwanaga. 1990. Pili of Vibrio cholerae non-O1. Infect. Immun. 58:1640-1646.
310. Nalin, D. R., V. Daya, A. Reid, M. M. Levine, and L. Cisneros. 1979. Adsorption and growth of Vibrio cholerae on chitin. Infect. Immun. 25:768-770.
311. Nalin, D. R., M. M. Levine, R. B. Hornick, E. J. Bergquist, D. Hoover, H. P. Holley, D. Waterman, J. VanBlerk, S. Matheny, S. Sotman, and M. Kennels. 1979. The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera. Trans. R. Soc. Trop. Med. Hyg. 73:10-14.
312. Nambiar, M. P., T. Oda, C. Chen, Y. Kuwazuru, and H. C. Wu. 1993. Involvement of the Golgi region in the intracellular trafficking of cholera toxin. J. Cell. Physiol. 154:222-228.
313. Nataro, J. P., A. Wright, G. Morris, L. Guers, C. Tacket, and M. M. Levine. 1992. Evaluation of rapid diagnostic methods for the detection of Vibrio cholerae in the stools of volunteers, p. 242. In Program and Abstracts of the 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
314. Nath, G., and S. C. Sanyal. 1992. Emergence of Vibrio cholerae O1 resistant to vibriostatic agent O/129. Lancet 340:366-367.
315. Nilsson, O., J. Cassiito, P.-A. Larsson, M. Jodal, P. Lidberg, H. Ahlman, A. Dahlström, and O. Lundgren. 1983. 5-Hydroxytryptamine and choiera secretion: a histochemical and physiological study in cats. Gut 24:542-548.
316. Nishibuchi, M., A. Fasano, R. G. Russell, and J. B. Kaper. 1992. Enterotoxigenicity of Vibrio parahaemolyticus with and without genes encoding thermostable direct hemolysin. Infect. Immun. 60:3539-3545.
317. Noriki, H. 1976. Evaluation of toxoid field trial in the Phillipines, p. 302-310. In Proceedings of the 12th Joint Conference on Cholera, U.S.-Japan Cooperative Medical Science Program. Fuji, Tokyo.
318. Northrup, R. S. 1969. Antibiotics in cholera therapy. J. Pak. Med. Assoc. 19:363-365.
319. O'Brien, A. D., M. E. Chen, R. K. Holmes, J. Kaper, and M. M. Levine. 1984. Environmental and human isolates of Vibrio cholerae and Vibrio parahaemofyticus produce a Shigella dysenleriae 1 (Shiga)-like cytotoxin. Lancet i:77-78.
320. O'Brien, A. D., and F. A. Kapral. 1976. Increased cyclic adenosine 3',5'-monophosphate content in guinea pig ilcum after exposure to Stapliyhcoccua aureus delta-toxin. Infect. Immun. 13:152-162.
321. Ogawa, A., J.-I. Kato, H. Watanabe, B. G. Nair, and T. Takeda. 1990. Cloning and nucleotide sequence of a heat-stable enterotoxin gene from Vibrio choleme non-O1 isolated from a patient with traveler's diarrhea. Infect. Immun. 58:3325-3329.
322. Ogawa, A., and T. Takeda. 1993. The gene encoding the heat-stable enterotoxin of Vibno cholerae is Hanked by 123-hasc pair direct repeats. Microbiol. Immunol. 37:607-616.
323. Ogierman, M. A., and P. A. Manning. 1992. Homology of TcpN, a putative regulatory protein of Vibrio cholerae, to the AraC family of transcriptional activators. Gene 116:93-97.
324. Ogierman, M. A., and P. A. Manning. 1992. TCP pilus biosynthesis in Vibrio cholerae O1 : gene sequence of tcpC encoding an outer membrane lipoprotein. FEMS Microbiol. Lett. 97:179-184.
325. Ogierman, M. A., S. Zabihi, L. Mourtzios, and P. A. Manning. 1993. Genetic organization and sequence of the promoter-distal region of the tcp gene cluster of Vibrio cholerae. Gene 126:51-60.
326. Olsvik, O., J. Wahlberg, B. Petterson, M. Uhlén, T. Popovic, I. K. Wachsmuth, and P. I. Fields. 1993. Use of automated sequencing of polymerase chain reaction-generated amplicons to identify three types of cholera toxin subunit B in Vibrio cholerae O1 strains. J. Clin. Microbiol. 31:22-25.
327. Osek, J., A.-M. Svennerholm, and J. Holmgren. 1992. Protection against Vibrio cholerae El Tor infection by specific antibodies against mannosebinding hemagglutinin pili. Infect. Immun. 60:4961-4964.
328. O'Shaughnessy, W. B. 1832. Report on the chemical pathology of the malignant cholera. Lancet i:929-936.
329. Owen, R. L., N. F. Pierce, R. T. Apple, and W. C. Cray, Jr. 1986. M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration. J. Infect. Dis. 153:1108-1118.
330. Pal, A., T. Ramamurthy, R. K. Bhadra, T. Takeda, T. Shimada, Y. Takeda, G. B. Nair, S. C. Pal, and S. Chakrabarti. 1992. Reassessment of the prevalence of heat-stable enterotoxin (NAG-ST) among environmental Vibno cholerae non-O1 strains isolated from Calcutta, India, by using a NAG-ST DNA probe. Appl. Environ. Microbiol. 58:2485-2489.
331. Pal, S. C. 1992. Laboratory diagnosis, p. 229-251. In D. Barua and W. B. Greenough, III (ed.), Cholera. Plenum Medical Book Co., New York.
332. Pan American Health Organization. 1991. Cholera situation in the Americas. Epidemiol. Bull. 12:1-4.
333. Parsot, C., and J. J. Mekalanos. 1990. Expression of ToxR, the transcriptional activator of the virulence factors in Vibrio cholerae, is modulated by the heat shock response. Proc. Natl. Acad. Sci. USA 87:9898-9902.
334. Parsot, C., E. Taxman, and J. J. Mekalanos. 1991. ToxR regulates the production of lipoproteins and the expression of serum resistance in Vibrio cholerae. Proc. Natl. Acad. Sci. USA 88:1641-1645.
335. Payne, S, M., and R. A. Finkelstein. 1978. Siderophore production by Vibrio cholerae. Infect. Immun. 20:310-311.
336. Pearson, G. D., V. J. DiRita, M. B. Goldberg, S. A. Boyko, S. B. Calderwood, and J. J. Mekalanos. 1990. New attenuated derivatives of Vibrio cholerae. Res. Microbiol. 141:893-899.
337. Pearson, G. D., and J. J. Mekalanos. 1982. Molecular cloning of Vibrio cholerae enterotoxin genes in Escherichia coli K-12. Proc. Natl. Acad. Sci. USA 79:2976-2980.
338. Pearson, G. D. N., A. Woods, S. L. Chiang, and J. J. Mekalanos. 1993. CTX genetic element encodes a site-specific recombination system and an intestinal colonization factor. Proc. Natl. Acad. Sci. USA 90:3750-3754.
339. Peek, J. A., and R. K. Taylor. 1992. Characterization of a periplasmic thiol:disulfide interchange protein required for the functional maturation of secreted virulence factors of Vibrio cholerae. Proc. Natl. Acad. Sci. USA 89:6210-6214.
340. Peltola, H., A. Siitonen, H. Kyrönseppä, I. Simula, L. Mattila, P. Oksanen, M. J. Kataja, and M. Cadoz. 1991. Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 338:1285-1289.
341. Peterson, J. W. 1979. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine. Infect. Immun. 26:528-533.
342. Peterson, J. W., K. E. Hejtmancik, D. E. Markel, J. P. Craig, and A. Kurosky. 1979. Antigenic specificity of neutralizing antibody to cholera toxin. Infect. Immun. 24:774-779.
343. Peterson, J. W., and L. G. Ochoa. 1989. Role of prostaglandins and cAMP in the secretory effects of cholera toxin. Science 245:857-859.
344. Peterson, J. W., J. C. Reitmeyer, C. A. Jackson, and G. A. S. Ansari. 1991. Protein synthesis is required for cholera toxin-induced stimulation of arachidonic acid metabolism. Biochim. Biophys. Acta 1092:79-84.
345. Peterson, K. M., and J. J. Mekalanos. 1988. Characterization of the Vibrio cholerae ToxR regulon: identification of novel genes involved in intestinal colonization. Infect. Immun. 56:2822-2829.
346. Pierce, N. F. 1973. Differential inhibitory effects of cholera toxoids and ganglioside on the enterotoxin of Vibrio cholerae and Escherichia coli. J. Exp. Med. 137:1009-1023.
347. Pierce, N. F., W. C. Cray, Jr., and J. B. Sacci, Jr. 1982. Oral immunization of dogs with purified cholera toxin, crude cholera toxin, or B subunit: evidence for synergistic protection by antitoxic and antibacterial mechanisms. Infect. Immun. 37:687-694.
348. Pierce, N. F., J. B. Kaper, J. J. Mekalanos, and W. C. Cray. 1985. Role of cholera toxin in enteric colonization by Vibrio cholerae O1 in rabbits. Infect. Immun. 50:813-816.
349. Pierce, N. F., and A. Mondai. 1974. Clinical features of cholera, p. 209-220. In D. Barua and W. Burrows (ed.), Cholera. W. B. Saunders Co., Philadelphia.
350. Pohlner, J., T. F. Meyer, M. B. Jalajakumari, and P. A. Manning. 1986. Nucleotide sequence of ompV, the gene for a major Vibrio cholerae outer membrane protein. Mol. Gen. Genet. 205:494-500.
351. Pollitzer, R. 1959. Cholera. World Health Organization, Geneva.
352. Pollitzer, R. 1959. History of the disease, p. 11-50. In R. Pollitzer (ed.), Cholera. World Health Organization. Geneva.
353. Popovic, T., C. Bopp, O. Olsvik, and K. Wachsmuth. 1993. Epidemiologie application of a standardized ribotype scheme for Vibrio cholerae O1. J. Clin. Microbiol. 31:2474-2482.
354. Popovic, T., P. I. Fields, and Ø. Olsvik. 1994. Detection of cholera toxin genes, p. 41-52. In I. K. Wachsmuth, P. A. Blake, and 0. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
355. Public Health Laboratory Service. 1993. Vibrio cholerae O139 and epidemic cholera. Commun. Dis. Rep. Weekly 3:173.
356. Rahman, M., D. A. Sack, A. Wadood, M. Yasmin, and A. Latif. 1989. Rapid identification of Vibrio cholerae serotype O1 from primary isolation plates by a coagglutination test. J. Med. Microbiol. 28:39-41.
357. Ramamurthy, T., S. K. Bhattacharya, Y. Uesaka, K. Horigome, M. Paul, D. Sen, S. C. Pal, T. Takeda, Y. Takeda, and G. B. Nair. 1992. Evaluation of the bead enzyme-linked immunosorbent assay for detection of cholera toxin directly from stool specimens. J. Clin. Microbiol. 30:1783-1786.
358. Ramamurthy, T., S. Garg, R. Sharma, S. K. Bhattacharya, G. Balakrish Nair, T. Shimada, T. Takeda, T. Karasawa, H. Kurazano, A. Pal, and Y. Takeda. 1993. Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India. Lancet 341:703-704.
359. Ramamurthy, T., A. Pal, P. K. Bag, S. K. Bhattacharya, G. B. Nair, H. Kurozano, S. Yamasaki, H. Shirai, T. Takeda, Y. Uesaka, K. Horigome, and Y. Takeda. 1993. Detection of cholera toxin gene in stool specimens by polymerase chain reaction: comparison with bead enzyme-linked immunosorbent assay and culture method for laboratory diagnosis of cholera. J. Clin. Microbiol. 31:3068-3070.
360. Ramamurthy, T., A. Pal, S. C. Pal, and G. Balakrish Nair. 1992. Taxonomical implications of the emergence of high frequency of occurrence of 2,4-diamino-6,7-diisopropylpteridine-resistant strains of Vibrio cholerae from clinical cases of cholera in Calcutta, India. J. Clin. Microbiol. 30:742-743.
361. Redmond, J. W. 1979. The structure of the O-antigenic side chain of the lipopolysaccharide of Vibrio cholerae 569B (Inaba). Biochim. Biophys. Acta 584:346-352.
362. Reitmeyer, J. C., and J. W. Peterson. 1990. Stimulatory effects of cholera toxin on arachidonic acid metabolism in Chinese hamster ovary cells. Proc. Soc. Exp. Biol. Med. 193:181-184.
363. Rennets, M. B., M. M. Levine, V. Daya, P. Angle, and C. Young. 1980. Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories. J. Infect. Dis. 142:328-331.
364. Rhine, J. A., and R. K. Taylor. 1994. TcpA pilin sequences and colonization requirements for Ol and O139 Vibrio cholerae. Mol. Microbiol. 13:1013-1020.
365. Rice, E. W., C. J. Johnson, R. M. Clark, K. R. Fox, D. J. Reasoner, M. E. Dunnigan, P. Panigrahi, J. A. Johnson, and J. G. Morris, Jr. 1992. Chlorine and survival of "rugose" Vibrio cholerae. Lancet 340:740. (Letter.).
366. Richardson, K. 1991. Roles of motility and flagellar structure in pathogenicity of Vibrio cholerae: analysis of motility mutants in three animal models. Infect. Immun. 59:2727-2736.
367. Richardson, K., J. B. Kaper, and M. M. Levine. 1989. Human immune sponse to Vibrio choleras O1 whole cells and isolated outer membrane antigens. Infect. Immun. 57:495-501.
368. Richardson, K., J. Michalski, and J. B. Kaper. 1986. Hemolysin production and cloning of two hemolysin determinants from classical Vibno cholerae. Infect. Immun. 54:415-420.
369. Richardson, K., and C. D. Parker. 1985. Identification and occurrence of Vibrio cholerae flagellar core proteins in isolated outer membrane. Infect. Immun. 47:674-679.
370. Richardson, S. H. 1969. Factors influencing in vitro skin permeability factor production by Vibrio cholerae. J. Bacteriol. 100:27-34.
371. Richardson, S. H. 1994. Host susceptibility, p. 273-293. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
372. Richardson, S. H. 1994. Animal models in cholera research, p. 203-226. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular ro global perspectives. ASM Press, Washington, D.C.
373. Richardson, S. H., J. C. Giles, and K. S. Kruger. 1984. Sealed adult mice: new model for enterotoxin evaluation. Infect. Immun. 43:482-486.
374. Ries, A. A., D. J. Vugia, L. Beingolea, A. M. Palacios, E. Vasquez, J. G. Wells, N. G. Baca, D. L. Swerdlow, M. Pollack, N. H. Bean, L. Seminario, and R. V. Tauxe. 1992. Cholera in Piura, Peru: a modern urban epidemic. J. Infect. Dis. 166:1429-1433.
375. Roberts, A. B., J. R. Harris, T. Taitai, T. Taraam, J. Tekanene, A. Cati, T. Flood, and M. Teburae. 1979. Cholera in the Gilbert Islands. II. Clinical and laboratory findings. Am. J. Trop. Med. Hyg. 28:685-691.
376. Roberts, N. C., R. J. Siebeling, J. B. Kaper, and H. B. Bradford, Jr. 1982. Vibrios in the Louisiana Gulf Coast environment. Microb. Ecol. 8:299-312.
377. Robins-Browne, R. M., C. R. Young, M. M. Levine, and J. P. Craig. 1980. Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: sensitivity and specificity. Infect. Immun. 27:497-500.
378. Rodman, D. M., and S. Zamudio. 1991. The cystic fibrosis heterozygote - advantage in surviving cholera? Med. Hypotheses 36:253-258.
379. Roszak, D. B., and R. R. Colwell. 1987. Survival strategies of bacteria in the natural environment. Microbiol. Rev. 51:365-379.
380. Rowe, B., and J. A. Frost. 1992. Vibrio phages and phage-typing, p. 95-105. In D. Barua and W. B. Greenough, III (ed.), Cholera. Plenum Medical Book Co., New York.
381. Sack, R. B., and D. Barua. 1965. The fluorescent antibody technique in the direct examination of cholera stool, p. 50-56. In Proceedings of the Cholera Research Symposium (Jan. 24-29, 1965, Honolulu). U.S. Government Printing Office, Washington, D.C.
382. Sack, R. B., and C. C. J. Carpenter. 1969. Experimental canine cholera. I. Development of the model. J. Infect. Dis. 119:138-149.
383. Sack, R. B., and C. E. Miller. 1969. Progressive changes of vibrio serotypes in germ-free mice infected with Vibrio cholerae. J. Bacteriol. 99:688-695.
384. Sack, R. B., and W. M. Spira. 1986. Animal models of acute diarrheal diseases of bacterial etiology, p. 43. In O. Zak (ed.), Experimental models in antimicrobial chemotherapy, vol. 2. Academic Press, Inc., London.
385. Saha, S., and S. C. Sanyal. 1988. Cholera toxin gene-positive Vibrio cholerae O1 Ogawa and Inaba strains produce the new cholera toxin. FEMS Microbiol. Lett. 50:113-116.
386. -) strains of Vibrio cholerae O1. J. Med. Microbiol. 32:33-37.
387. Sakazaki, R. 1992. Bacteriology of Vibrio and related organisms, p. 37-55. In D. Barua and W. B. Greenough, III (ed.), Cholera. Plenum Medical Book Co., New York.
388. Sakazaki, R., and T. Shimada. 1977. Serovars of Vibrio cholerae. Jpn. J. Med. Sci. Biol. 30:279-282.
389. Sanchez, J., S, Johansson, B. Lowenadler, A. M. Svennerholm, and J. Holmgren. 1990. Recombinant cholera toxin B suhunit and gene fusion proteins for oral vaccination. Res. Microbiol. 141:971-979.
390. Sanyal, S. C., K. Alam, P. K. B. Neogi, M. I. Huq, and K. A. Al-Mahmud. 1983. A new cholera toxin. Lancet i:1337.
391. Schödel, F., H. Will, S. Johansson, J. Sanchez, and J. Holmgren. 1991. Synthesis in Vibrio cholerae and secretion of hepatitis B virus antigens fused to Escherichia coli heat-labile enterotoxin subunit B. Gene 99:255-259.
392. Schrank, G. D., and W. F. Verwey. 1976. Distribution of cholera organisms in experimental Vibrio cholerae infections: proposed mechanisms of pathogenesis and antibacterial immunity. Infect. Immun. 13:195-203.
393. Sciortino, C. V., and R. A. Finkelstein. 1983. Vibrio cholerae expresses iron-regulated outer membrane proteins in vivo. Infect. Immun. 42:990-996.
394. Sears, S. D., K. Richardson, C. Young, C. D. Parker, and M. M. Levine. 1984. Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae. Infect. Immun. 44:439-444.
395. Selander, R. K., D. A. Caugant, H. Ochman, J. M. Musser, M. N. Gilmour, and T. S. Whittam. 1986. Methods of multilocus enzyme elecrrophoresis for bacterial population genetics and systematics. Appl. Environ. Microbiol. 51:873-884.
396. Sengupta, D. K., T. K. Sengupta, and A. C. Ghose. 1992. Major outer mbrane proteins of Vibrio cholerae and their role in induction of protective immunity through inhibition of intestinal colonization. Infect. Immun. 60:4848-4855.
397. Shandera, W. X., B. Hafkin, D. L. Martin, J. P. Taylor, D. L. Maserang, J. G. Wells, M. Kelly, K. Ghandi, J. B. Kaper, J. V. Lee, and P. A. Blake. 1983. Persistence of cholera in the United States. Am. J. Trop. Med. Hyg. 32:812-817.
398. Sharma, D. P., U. H. Stroeher, C. J. Thomas, P. A. Manning, and S. R. Attridge. 1989. The toxin-coregulated pilus (TCP) of Vibrio cholerae: molecular cloning of genes involved in pilus biosynthesis and evaluation of TCP as a protective antigen in the infant mouse model. Microb. Pathog. 7:437-448.
399. Shaw, C. E., and R. K. Taylor. 1990. Vibrio cholerae O395 tcpA pilin gene sequence and comparison of predicted protein structural features to those of type 4 pilins. Infect. Immun. 58:3042-3049.
400. Shimada, T., G. B. Nair, B. C. Deb, M. J. Albert, R. B. Sack, and Y. Takeda. 1993. Outbreak of Vibrio cholerae non-O1 in India and Bangladesh. Lancet 341:1347.
401. Shimada, T., and R. Sakazaki. 1973. R antigen of Vibrio cholerae. Jpn. J. Med. Sci. Biol. 26:155-160.
402. Shimada, T., R. Sakazaki, S. Fujimara, et al. 1990. A new selective differential agar medium for isolation of Vibrio cholerae O1: PMT (polymixin mannose-tellurite agar). Jpn. J. Med. Sci. Biol. 43:37-41.
403. Shinoda, S., R. Kariyama, M. Ogawa, Y. Takeda, and T. Miwatani. 1976. Flagellar antigens of various species of the genus Vibrio and related genera. Int. J. Syst. Bacteriol. 26:97-101.
404. Shirai, H., M. Nishibuchi. T. Ramamurthy, S. K. Bhattacharya, S. C. Pal, and Y. Takeda. 1991. Polymerase chain reaction for detection of the cholera enterotoxin operon of Vibrio cholerae. J. Clin. Microbiol. 29:2517-2521.
405. Shousha, A. T. 1947. Cholera epidemic in Egypt (1947). A preliminary report. Bull. W. H. O. 1:353-381.
406. Siddique, A. K., A. H. Baqui, A. Eusof, K. Haider, M. A. Hossain, I. Bashir, and K. Zaman. 1991. Survival of classic cholera in Bangladesh. Lancet 337:1125-1127.
407. Siebeling, R. J., L. B. Adams, Z. Yusof, and A. D. Larson. 1984. Antigens and serovar-specific antigens of Vibrio cholerae, p. 33-58. In R. R. Colwell (ed.), Vibrios in the environment. John Wiley & Sons, New York.
408. Sigel, S. P., and S. M. Payne. 1982. Effect of iron limitation on growth, siderophore production, and expression of outer membrane proteins of Vibrio cholerae. J. Bacteriol. 150:148-155.
409. Sigel, S. P., J. A. Stoebner, and S. M. Payne. 1985. Iron-vibriobactin transport system is not required for virulence of Vibrio cholerae. Infect. Immun. 47:360-362.
410. Simonson, J. G., and R. J. Siebeling. 1988. Coagglutination of Vibrio cholerae, Vibrio mimicus, and Vibrio vulnificus with anti-flagellar monoclonal antibody. J. Clin. Microbiol. 26:1962-1966.
411. Sinha, V. B., A. Jacob, R. Srivastava, J. B. Kaper, and B. S. Srivastava. 1993. Identification of the flagellar antigens of Vibno cholerae El Tor and their role in protection. Vaccine 11:372-375.
412. Sircar, B. K., P. Dutta, S. P. De, S. N. Sikdar. B. C. Deb, and S. C. Pal. 1981. ABO blood group distributions in diarrhoea cases including cholera in Calcutta. Ann. Hum. Biol. 8:289-291.
413. Sixma, T. K., S. E. Pronk, K. H. Kalk, E. S. Wartna, B. A. M. van Zanten, B. Witholt, and W. G. J. Hol. 1991. Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coll. Nature (London) 351: 371-377.
414. Sjöqvist, A., J. Cassuto, M. Jodal, and O. Lundgren. 1992. Actions of serotonin antagonists on cholera-toxin-induced intestinal fluid secretion. Acta Physiol. Scand. 145:229-237.
415. Smith, H. L., Jr. 1979. Serotyping of non-cholera vibrios. J. Clin. Microbiol. 10:85-90.
416. Smith, H. W., and M. A. Linggood. 1971. Observations on the pathogenic properties of the K88, Hly and Ent plasmids of Escherichia coli with particular reference to porcine diarrhoea. J. Med. Microbiol. 4:467-485.
417. Snow, J. 1855. On the mode of communication of cholera, 2nd ed., p. 1-162. J. Churchill, London.
418. Snyder, J. D., D. T. Allegra, M. M. Levine, J. P. Craig, J. C. Feeley, W. E. DeWitt, and P. A. Blake. 1981. Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States. J. Infect. Dis. 143:182-187.
419. Spangler, B. D. 1992. Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin. Microbiol. Rev. 56:622-647.
420. Speelman, P., G. H. Rabbani, K. Bukhave, and J. Rask-Madsen. 1985. Increased jejunal prostaglandin E, concentrations in patients with acute cholera. Gut 26:188-193.
421. 419a.Sperandio, V., J. A. Girón, W. D. Silveira, J. Michalski, and J. B. Kaper. 1994. Characterization of the outer membrane protein OmpU of Vibrio cholerae, p. 248. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
422. Spira, W. M., A. Huq, Q. S. Ahmed, and Y. A. Saeed. 1981. Uptake of Vibrio cholerae biotype eltor from contaminated water by water hyacinth (Eichora crassipes). Appl. Environ. Microbiol. 42:550-553.
423. Spira, W. M., M. U. Khan, Y. A. Saeed, and M. A. Sattar. 1980. Microbiological surveillance of intra-neighbourhood El Tor cholera transmission in rural Bangladesh. Bull. W. H. O. 58:731-740.
424. Spira, W. M., D. A. Sack, P. J. Fedorka-Cray, S. Sanyal, J. Madden, and B. McCardell. 1986. Description of a possible new extracellular virulence factor in nontoxigenic Vibrio cholerae O1, p. 263-270. In S. Kuwahara, and N. F. Pierce (ed.), Advances in research on cholera and related diarrheas, vol. 3. KTK Scientific Publishers, Tokyo.
425. Spira, W. M., R. B. Sack, and J. L. Froehlich. 1981. Simple adult rabbit model for Vibrio cholerae and enterotoxigenic Escherichia coli diarrhea. Infect. Immun. 32:739-747.
426. Staerk, J., H. J. Ronneberger, and H. Wiegandt. 1974. Neuraminidase, a virulence factor in Vibrio cholerae infection? Behring Inst. Mitt. 55:145-146.
427. St. Louis, M. E., J. D. Porter, A. Hela, K. Drame, N. Hargrett-Bean, J. G. Wells, and R. V. Tauxe. 1990. Epidemic cholera in west Africa: the role of food handling and high-risk foods. Am. J. Epidemiol. 131:719-728.
428. Stoebner, J. A., J. R. Butterton, S. B. Calderwood, and S. M. Payne. 1992. Identification of the vibriobactin receptor of Vibrio cholerae. J. Bacteriol. 174:3270-3274.
429. Stoebner, J. A., and S. M. Payne. 1988. Iron-regulated hemolysin production and utilization of heme and hemoglobin by Vibrio cholerae. Infect. Immun. 56:2891-2895.
430. Stroeher, U. H., L. E. Karageorgos, R. Morona, and P. A. Manning. 1992. Serotype conversion in Vibrio cholerae O1. Proc. Nail. Acad. Sci. USA 89:2566-2570.
431. Su-Arehawaratana, P., P. Singharaj, D. N. Taylor, C. Hoge, A. Trofa, K. Kuvanont, S. Migasena, P. Pitisuttitham, Y. L. Lim, G. Losonsky, J. B. Kaper, S. S. Wasserman, S. Cryz, P. Echeverria, and M. M. Levine. 1992. Safety and immunogenicity of different immunization regimens of CVD 103-HgR live oral cholera vaccine in soldiers and civilians in Thailand. J. Infect. Dis. 165:1042-1048.
432. Suharyono, C. Simanjuntak, N. Witham, N. Punjabi, D. G. Heppner, G. Losonsky, H. Totosudirjo, A. R. Rifai, J. Clemens, Y. L. Lim, D. Burr, S. S. Wasserman, J. Kaper, K. Sorenson, S. Cryz, and M. M. Levine. 1992. Safety and immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR in 5-9-year-old Indonesian children. Lancet 340:689-694.
433. Sun, D., D. M. Tillman, T. N. Marion, and R. K. Taylor. 1990. Production and characterization of monoclonal antibodies to the toxin coregulated pilus (TCP) of Vibrio cholerae that protect against experimental cholera in infant mice. Serodiagm. Immunother. Infect. Dis. 4:73-81.
434. Sun, D. X., J. J. Mekalanos, and R. K. Taylor. 1990. Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model. J. Infect. Dis. 161:1231-1236.
435. Svennerholm, A.-M. 1980. The nature of protective immunity in cholera, p. 171-184. In O. Ouchterlony and J. Holmgren (ed.), Cholera and related diarrheas. 43rd Nobel Symposium, Stockholm, 1978. S. Karger, Basel.
436. Svennerholm, A. M., and J. Holmgren. 1976. Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/ toxoid. Infect. Immun. 13:735-740.
437. M1-ELISA) procedure. Curr. Microbiol. 1:19-23.
438. Svennerholm, A.-M., and J. Holmgren. 1986. Oral combined B subunitwhole cell cholera vaccine, p. 33-43. In J. Holmgren, A. Lindberg, and R. Möllby (ed.), Development of vaccines and drugs against diarrhea, 11th Nobel Conference, Stockholm 1985. Studentlittcratur, Lund, Sweden.
439. Svennerholm, A.-M., G. Jonson, and J. Holmgren. 1994. Immunity to Vibrio cholerae infection, p. 257-271. In I. K. Wachsmuth, P. A. Blake, and Ø. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
440. Svennerholm, A. M., G. J. Stromberg, and J. Holmgren. 1983. Purification of Vibro cholerae soluble hemagglutinin and development of enzyme-linked immunosorbent assays for antigen and antibody quantitations. Infect. Immun. 41:237-243.
441. Swaddiwudhipong, W., and K. Limpakarnjanarat. 1991. An outbreak of El Tor cholera in an institution for the mentally retarded in Nonthaburi, June-July 1987. J. Med. Assoc. Thailand 74:306-310.
442. Swerdlow, D. L., E. D. Mintz, M. Rodriguez, E. Tejada, C. Ocampo, L. Espejo, K. D. Greene, W. Saldana, L. Seminario, R. V. Tauxe, J. G. Wells, N. H. Bean, A. A. Ries, M. Pollack, B. Vertiz, and P. A. Blake. 1992. Waterborne transmission of epidemic cholera in Trujillo, Peru: lessons for a continent at risk. Lancet 340:28-32.
443. Swerdlow, D. L., and A. A. Ries. 1992. Cholera in the Americas: guidelines for the clinician. JAMA 267:1495-1499.
444. Swerdlow, D. L., and A. A. Ries. 1993. Vibrio cholerae non-O1-the eighth pandemic? Lancet 342:382-383.
445. Tabtieng, R., S. Wattanasri, P. Echeverria, J. Seriwatana, L. Bodhidatta, A. Chatkaeomorakot, and B. Rowe. 1989. An epidemic of Vibrio cholerae El Tor Inaba resistant to several antibiotics with a conjugative group C asmid coding for type II dihydrofolate reductase in Thailand. Am. J. Trop. Med. Hyg. 41:680-686.
446. Tacket, C. O., J. Clemens, and J. B. Kaper. 1992. Cholera vaccines, p. 53-68. In R. W. Ellis (ed.), Vaccines: new approaches to immunological problems. Butterworths, Boston.
447. Tacket, C. O., B. Forrest, R. Morona, S. R. Attridge, J. LaBrooy, B. D. Tall, M. Reymann, D. Rowley, and M. M. Levine. 1990. Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a. Infect. Immun. 58:1620-1627.
448. Tacket, C. O., G. Losonsky, J. P. Nataro, S. J. Cryz, R. Edelman, A. Fasano, J. Michalski, J. B. Kaper, and M. M. Levine. 1993. Safety, immunogenicity, and transmissibility of live oral cholera vaccine candidate CVD110, a △ctxA △zot △ace derivative of El Tor Ogawa Vibrio cholerae. J. Infect. Dis. 168:1536-1540.
449. Tacket, C. O., G. Losonsky, J. P. Nataro, S. J. Cryz, R. Edelman, J. B. Kaper, and M. M. Levine. 1992. Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR. J. Infect. Dis. 166:837-841.
450. Tacket, C. O., G. Losonsky, J. P. Nataro, S. S. Wasserman, S. J. Cryz, R. Edelman, and M. M. Levine. Extension of the volunteer challenge model to study South American cholera in a population of volunteers with predominantly blood group antigen O. Trans. R. Soc. Trop. Med. Hyg., in press.
451. Takeda, T., Y. Peina, A. Ogawa, S. Dohi, H. Abe, G. B. Nair, and S. C. Pal. 1991. Detection of heat-stable enterotoxin in a cholera toxin gene-positive strain of Vibrio cholerae O1. FEMS Microbiol. Lett. 80:23-28.
452. Takeda, Y., T. Takeda, S. C. Pal, and G. B. Nair. 1992. Serovar, biotype, phage type, toxigenicity and antibiotic susceptibility patterns of Vibrio cholerae isolated during two consecutive cholera seasons (1989-90) in Calcutta. Indian J. Med. Res. Sect. A 95:125-129.
453. Takeya, K., T. Otohuji, and H. Tokiwa. 1981. FK phage for differentiating the classical and El Tor groups of Vibrio cholerae. J. Clin. Microbiol. 14:222-224.
454. Tamplin, M. L., and C. Carrillo. 1991. Environmental spread of Vibrio cholerae in Peru. Lancet 338:1216-1217.
455. Tamplin, M. L., R. R. Colwell, S. Hall, K. Kogure, and G. R. Strichartz. 1987. Sodium-channel inhibitors produced by enteropathogenic Vibrio cholerae and Aeromonas hydrophila. Lancet i:975.
456. Tamplin, M. L., A. L. Gauzens, A. Huq, D. A. Sack, and R. R. Colwell. 1990. Attachment of Vibrio cholerae serogroup O1 to Zooplankton and phytoplankton of Bangladesh waters. Appl. Environ. Microbiol. 56:1977-1980.
457. Tamura, K., S. Shimoda, and L. M. Prescott. 1971. Vibrio agar: a new plating medium for isolation of V. cholerae. Jpn. J. Med. Sci. Biol. 24:125-127.
458. Tauxe, R. V., E. D. Mintz, R. E. Quick, A. A. Ries, D. L. Swerdlow, and P. A. Blake. 1993. Epidemic cholera in Latin America: epidemiologic investigations of cholera transmission and prospects for sustainable non-vaccine prevention measures, p. 57-62. In Abstracts of the Twenty-ninth Joint Conference on Cholera and Related Diarrheal Diseases. National Institutes of Health, Bethesda, Md.
459. Taylor, J. L., J. Tuttle, T. Pramukul, K. O'Brien, T. J. Barrett, B. Jolbitado, Y. L. Lim, D. Vugia, J. G. Morris, Jr., R. V. Tauxe, and D. M. Dwyer. 1993. An outbreak of cholera in Maryland associated with imported commercial frozen fresh coconut milk. J. Infect. Dis. 167:1330-1335.
460. Taylor, R., C. Shaw, K. Peterson, P. Spears, and J. Mekalanos. 1988. Safe, live Vibrio cholerae vaccines? Vaccine 6:151-154.
461. Taylor, R. K., V. L. Miller, D. B. Furlong, and J. J. Mekalanos. 1987. Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin. Proc. Natl. Acad. Sci. USA 84:2833-2837.
462. Teppema, J. S., P. A. M. Guinée, A. A. Ibrahim, M. Pâques, and E. J. Ruitenberg. 1987. In vivo adherence and colonization of Vibrio cholerae strains that differ in hemagglutinating activity and motility. Infect. Immun. 55:2093-2102.
463. Terai, A., K. Baba, H. Shirai, O. Yoshida, Y. Takeda, and M. Nishibuchi. 1991. Evidence for insertion-sequence-mediated spread of the thermostable direct hemolysin gene among Vibrio species. J. Bacteriol. 173:5036-5046.
464. Towner, K. J., N. J. Pearson, F. S. Mhalu, and F. O'Grady. 1980. Resistance to antimicrobial agents of Vibrio cholerae El Tor strains isolated during the fourth cholera epidemic in the United Republic of Tanzania. Bull. W. H. O. 58:747-751.
465. Trucksis, M., J. E. Galen, J. Michalski, A. Fasano, and J. B. Kaper. 1993. Accessory cholera enterotoxin (Ace), the third toxin of a Vibrio cholerae virulence cassette. Proc. Natl. Acad. Sci. USA 90:5267-5271.
466. Twedt, R. M., J. M. Madden, J. M. Hunt, D. W. Francis, J. T. Peeler, A. P. Duran, W. O. Hebert, S. G. McCay, C. N. Roderick, G. T. Spite, and T. J. Wazenski. 1981. Characterization of Vibrio cholerae isolated from oysters. Appl. Environ. Microbiol. 41:1475-1478.
467. van Heyningen, W. E., and J. R. Seal. 1983. Cholera-the American scientific experience, 1947-1980. Westview Press, Boulder, Colo.
468. Varela, P., M. Rivas, N. Binsztein, M. L. Cremona, P. Herrmann, O. Burrone, R. A. Ugalde, and A. C. C. Frasch. 1993. Identification of toxigenic cholerae from the Argentine outbreak by PCR for ctx A1 and ctx A2-B. FEBS Lett. 315:74-76.
469. Voss, E., and S. R. Attridge. 1993. In vitro production of toxin-coregulated pili by Vibrio cholerae El Tor. Microb. Pathog. 15:255-268.
470. Wachsmuth, I. K., G. M. Evins, P. I. Fields, O. Olsvik, T. Popovic, C. A. Bopp, J. G. Wells, C. Carrillo, and P. A. Blake. 1993. The molecular epidemiology of cholera in Latin America. J. Infect. Dis. 167:621-626.
471. Wachsmuth, I. K., O. Olsvik, G. M. Evins, and T. Popovic. 1994. Molecular epidemiology of cholera, p. 357-370. In I. K. Wachsmuth, P. A. Blake, and 0. Olsvik (ed.), Vibrio cholerae and cholera: molecular to global perspectives. ASM Press, Washington, D.C.
472. Wang, F., T. Butler, G. H. Rabbani, and P. K. Jones. 1986. The acidosis of cholera: contributions of hyperproteinemia, lactic acidemia, and hyperphosphatemia to an increased serum anion gap. N. Engl. J. Med. 315:1591-1595.
473. Wanke, C. A., and R. L. Guerrant. 1987. Small-bowel colonization alone is a cause of diarrhea. Infect. Immun. 55:1924-1926.
474. Watten, R. H., F. M. Morgan, Y. N. Songkhla, B. Vanikaiti, and R. A. Phillips. 1959. Water and electrolyte studies in cholera. J. Clin. Invest. 38:1879-1889.
475. White, P. B. 1938. The rugose variant of vibrios. J. Pathol. Bacteriol. 46:1-6.
476. White, P. B. 1940. The characteristic hapten and antigen of rugose races of cholera and El Tor vibrios. J. Pathol. Bacteriol. 50:160-164.
477. Wilson, G. 1984. Cholera, p. 446-457. In G. Wilson, A. Miles, and M. T. Parker (ed.), Topley and Wilson's principles of bacteriology, virology and immunity, 7th ed., vol. 3. Williams and Wilkins, Baltimore.
478. Winner, L., III, J. Mack, R. Weltzin, J. J. Mekalanos, J. Kraehenbuhl, and M. R. Neutra. 1991. New model for analysis of mucosal immunity: intestinal secretion of specific monoclonal immunoglobulin A from hybridoma tumors protects against Vibrio cholerae infection. Infect. Immun. 59:977-982.
479. Woodward, W. E. 1971. Cholera reinfection in man. J. Infect. Dis. 123:61-66.
480. World Health Organization. 1980. Cholera surveillance. Weekly Epidemiol. Rec. 14:101-102.
481. Wright, A. C., Y. Guo, J. A. Johnson, J. P. Nataro, and J. G. Morris, Jr. 1992. Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J. Clin. Microbiol. 30:2302-2306.
482. Xu, H.-S., N. Roberts, F. L. Singleton, R. W. Attwell, D. J. Grimes, and R. R. Colwell. 1982. Survival and viability of non-culturable Escherichia coli and Vibrio cholerae in the estuarine and marine environment. Microb. Ecol. 8:313-323.
483. Yam, W. C., M. L. Lung, K. Y. Ng, and M. H. Ng. 1989. Molecular epidemiology of Vibrio cholerae in Hong Kong. J. Clin. Microbiol. 27:1900-1902.
484. Yamamoto, K., Y. Ichinose, N. Nakasone, M. Tanabe, M. Nagahama, J. Sakurai, and M. Iwanaga. 1986. Identity of hemolysins produced by Vibrio cholerae non-O1 and V. cholerae O1, biotype El Tor. Infect. Immun. 51:927-931.
485. Yamamoto, K., Y. Ichinose, H. Shinagawa, K. Makino, A. Nakata, M. Iwanaga, T. Honda, and T. Miwatani. 1990. Two-step processing for activation of the cytolysin/hemolysin of Vibrio cholerae Ol biotype El Tor: nucleotide sequence of the structural gene (hlyA) and characterization of the processed products. Infect. Immun. 58:4106-4116.
486. Yamamoto, T., T. Kamano, M. Uchimura, M. Iwanaga, and T. Yokota. 1988. Vibrio cholerae Ol adherence to villi and lymphoid follicle epithelium: in vitro model using formalin-treated human small intestine and correlation between adherence and cell-associated hemagglutinin levels. Infect. Immun. 56:3241-3250.
487. Yamamoto, T., T. Tamura, and T. Yokota. 1984. Primary structure of heat-labile enterotoxin produced by Escherichia coli pathogenic for humans. J. Biol. Chem. 259:5037-5044.
488. Yamamoto, T., and T. Yokota. 1983. Sequence of heat-labile enterotoxin of Escherichia coli pathogenic for humans. J. Bacteriol. 155:728-733.
489. Yamamoto, T., and T. Yokota. 1988. Electron microscopic study of Vibrio cholerae Ol adherence to the mucus coat and villus surface in the human small intestine. Infect. Immun. 56:2753-2759.
490. Yamamoto, T., and T. Yokota. 1989. Vibrio cholerae O1 adherence to human small intestinal M cells in vitro. J. Infect. Dis. 160:168-169.
491. Yancey, R. J., D. L. Willis, and L. J. Berry. 1979. Flagella-induced immunity against experimental cholera in adult rabbits. Infect. Immun. 25:220-228.
492. Yoh, M., K. Miyagi, Y. Matsumoto, K. Hayashi, Y. Takarada, K. Yamamoto, and T. Honda. 1993. Development of an enzyme-labeled oligonucleotide probe for the cholera toxin gene. J. Clin. Microbiol. 31:1312-1314.
493. Yu, J., H. Webb, and T. R. Hirst. 1992. A homologue of the Escherichia coli DsbA protein involved in disulphide bond formation is required for enterotoxin biogenesis in Vibrio cholerae. Mol. Microbiol. 6:1949-1958.